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Nucleic acids amplification methods can be extremely useful for the identification 
and quantitation of nucleic acid analytes, but are more difficult to adapt to the detection 
of non-nucleic acid targets. To facilitate the development of nucleic acid amplification 
for small molecule and protein analytes, we have developed the use of aptazyme and 
conformation-switching aptamers to generate amplification signals upon interaction with 
their cognate analytes.
We have developed chip-based rolling circle amplification (RCA) for the 
detection of ATP utilizing a DNA aptazyme that could catalyze the ligation and 
circularization of a single-stranded DNA substrate upon ATP recognition. The method 
has demonstrated that aptazyme-coupled chip-based RCA could sensitively detect ATP 
and the reproducible signals can be easily read and acquired within a few minutes. 
In addition to the design of aptazyme mediated ligation for the detection of small 
molecules, we have been interested in the adaptation of structure-switching aptamers to 
generate analyte-dependent ligations. We have developed a novel type of conformation-
switching aptamer that can be circularized by T4 DNA ligase upon interaction with its 
 viii
protein target, PDGF. Using this structure-switching aptamer real-time RCA can be used 
to quantitate PDGF down to low-nanomolar range, even against a background of cellular 
lysate. Our results also demonstrate that real-time RCA has advantages over chip-based 
RCA.
Furthermore, we have coupled conformation-switching aptamers with binding to 
an antisense oligonucleotide in a way that leads to ligation and the formation of a novel 
amplicon for real-time PCR. We have explored different strategies from four-piece to 
two-piece ligations. Our results show that the three-piece has sensitivity and simplicity 
over the four-piece ligation. However, both four-piece and three-piece ligations require 
ligation time as long as 8 hours, which is not practical for clinical diagnostics. Therefore, 
we have simplified the detection into a two-piece ligation, where the antisense sequence 
is attached to the aptamer and upon binding to protein analyte (PDGF or thrombin) the 
displaced antisense sequence is ligated to a substrate oligonucleotide. By real-time 
amplification (PCR) of the ligated product we find that the conformation-switching 
aptamers can sensitively and specifically detect thrombin or PDGF at picomolar level 
against a background of cellular lysate. The principal advantage of this method is that it 
can potentially be applied to a wide variety of analytes, thereby allowing the development 
of numerous amplificable aptamer biosensors. 
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Chapter 1: Introduction 
Nucleic acid technology is traditionally based on the recognitions of RNA or 
DNA via hybridization to complementary sequences. The discovery of naturally 
occurring catalytic RNA molecules (Kruger, Grabowski et al. 1982; Guerrier-Takada, 
Gardiner et al. 1983) and the development of in vitro selected ribozymes (Wilson and 
Szostak 1999; Schallmeiner, Oksanen et al. 2007) have demonstrated that nucleic acids 
are multitalented; capable of catalyzing various reactions. With these newly discovered 
functions, nucleic acids can be explored for new detection technologies, such as 
aptazyme and aptamer based detections for a variety of analytes. 
Aptamers are single-stranded DNA and RNA binding elements selected in vitro
by SELEX (systematic evolution of ligands by exponential enrichment) (Ellington and 
Szostak 1990; Tuerk and Gold 1990). Since their discovery about 17 years ago, aptamers 
have been selected against a variety of analytes, including inorganic ions, small organics, 
metabolites, peptides, proteins, and even whole viruses or cells (Proske, Blank et al. 
2005; Yan, Bell et al. 2005; Bunka and Stockley 2006; Lee, Stovall et al. 2006). In 
addition, manmade catalytic nucleic acids (aptazymes) have been generated by 
conjugation of aptamer and natural ribozymes and by similar schemes used for aptamer 
selections (Joyce 2004). 
ADVANTAGES OF APTAMERS AS BIOSENSORS
In vitro selected aptamers exhibit high affinity and specificity with their analytes 
as monoclonal antibodies do. For example, some anti-protein aptamers have Kd values in 
the low nanomolar range and can discriminate targets with very similar structures. 
Compared to monoclonal antibodies, aptamers can be easily synthesized and stored 
 2
without denaturation or degradation and it is relatively easy to incorporate a site-specific 
modification. Due to these characteristics, aptamers have become increasingly popular as 
biosensors for a wide range of analytical and diagnostic applications, broadly expanding 
the versatility of nucleic acid-based detection.    
APPLICATION OF APTAMERS FOR SENSING
In the recent decade, many technologies and strategies have been explored to 
make aptamer biosensors simpler, faster, more sensitive and more generalizable.  
As antibody substitutes for analyte capture 
Because aptamers are selected as binding reagents, the use of aptamers as 
antibody substitutes for analyte capture are very straightforward. Like antibodies, 
aptamers have proved to be very useful in ELISA, western blots and affinity purification. 
In an ELISA-like application developed by Drolet and colleagues an analyte (human 
vascular endothelial growth factor; hVEGF) was captured by immobilized  monoclonal 
anti-hVEGF antibodies (Drolet, Moon-McDermott et al. 1996). The detection limit (25 
pg/mL) and specificity were equivalent to those of typical antibody mediated sandwich 
assays. Baldrich et al. could detect <1 nM thrombin using a similar experimental strategy 
(Baldrich, Restrepo et al. 2004), much more sensitive than a direct binding (Kd: ~200 
nM) (Bock, Griffin et al. 1992). Liss et al. reported that aptamers as immobilized ligands 
in quartz crystal sensors could detect 0.5 nM of IgE and this was equivalent to antibodies 
immobilized on the same surface (Liss, Petersen et al. 2002). For western blot type 
applications, radiolabeled aptamers were used to detect different protein kinase C 
isozymes in filter binding assays where the bound species retained on the filter were 
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quantified after removing free aptamers by filtration (Conrad and Ellington 1996). The 
detection limits for IgE and thrombin were 46 pM and 40 nM, respectively, using 
fluorescently labeled aptamers in a capillary electrophoresis coupled with laser-induced 
fluorescence (CE-LIF) (German, Buchanan et al. 1998). Moreover, labeled aptamers 
were applied in cell sorting (Davis, Abrams et al. 1996; Davis, Lin et al. 1998), 
microbeads based assays (Rye and Nustad 2001; Yang, Li et al. 2003; Kirby, Cho et al. 
2004), capillary electrochromatography (Kotia, Li et al. 2000; Rehder and McGown 
2001), high-throughput screening assays (Green, Jellinek et al. 1996), fluorescence 
anisotropy (Potyrailo, Conrad et al. 1998; Fang, Cao et al. 2001; Yang, Fung et al. 2007) 
and  affinity chromatography (Romig, Bell et al. 1999; Gustafsdottir, Nordengrahn et al. 
2006).   
In summary, nucleic acid aptamers have demonstrated both sensitivity and 
specificity in diagnostic assays akin to monoclonal antibodies (Jayasena 1999). However, 
the limitation of antibody-like assays is that washes and separations are usually needed to 
remove background from the excessive binders.  
It has been known that aptamers recognize their analyte by forming 3-D shapes, 
and the binding conformations can be altered and manipulated by nucleic acid 
hybridizations. Therefore, it should be possible to construct a carefully engineered 
structure-switching aptamer used for detection without separating bound and unbound 
species, which can be performed directly in sample matrix without special and expensive 
instruments. 
Optical structure-switching signaling aptamers 
Optical (colorimetric or fluorometric) detections allow rapid and ideally real-time 
sample measurements. Fluorescent signaling aptamers have been extensively developed 
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based on the structure-switching strategies. As mentioned above, the recognition of 
analyte relies on both aptamer sequences and 3-D conformations, either the aptamers’ 
stable structures or in many cases their analyte-induced conformations. The analyte 
induced conformational changes can be monitored by fluorescence or colorimetric 
changes. To get a better handle on the possible structure-switching models, it is necessary 
to present the typical strategies for engineering optical structure-switching aptamers.  
Folding strategy 
In the folding strategy, the aptamer is naturally denatured or contains no 
minimum free energy structure in the absence of analyte, and then upon binding the 
analyte a stable structure is formed. When the aptamer is fluorescently labeled, the 
structure switches can change the micro-environment of the fluorescent moiety thus the 
fluorescent signal.   
For example, in the absence of thrombin the main conformation of the anti-
thrombin aptamer is a random coil in solution. Thrombin binding assists the aptamer to 
fold into a quadruplex structure. Li et al. labeled the two termini of the anti-thrombin 
aptamer with two fluorescent dyes that form a FRET pair (Li, Fang et al. 2002). Upon 
adding thrombin, the aptamer forms into a quadruplex structure and the two fluorophores 
are brought into proximity to FRET (Figure 1-1A) leading to decreased (fluorescein-
DABCYL pair) or increased (fluorescein-coumarin pair) fluorescence. Both methods 
resulted in similar apparent Kd values (5.20±0.49 nM vs 4.87±0.55 nM) and limits of 
detection (373±30 pM vs 429±63 pM). The analyte-induced conformational change can 
also be monitored using a dye that preferably intercalate into stacking bases. For 
example, Ho and Leclerc monitored the thrombin-aptamer binding with a polythiophene 
derivative (polymer 1), which exhibited different fluorescent colors when interacting with 
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unfolded and folded ssDNA (Ho and Leclerc 2004). The detection limit of this method 
was 2x10
-15 
mol (10 pM).      
Another approach is to design an unstable aptamer. In the absence of analyte, the 
aptamer stays at its unfolded form. When binding to the analyte, the folded structure of 
the aptamer becomes more stable, forcing terminal nucleic acid to hybridize. For 
example, the anti-PDGF aptamer was modified to be an open structure in the absence of 
PDGF but assumed its three-way junction structure when PDGF bound (Figure 1-1) 
(Fang, Sen et al. 2003). When the aptamer was labeled with a pair of fluorescent dyes, the 
folding leaded to fluorescence quenching. This ‘folding’ strategy was also applied to the 
detection of small molecule analyte such as cocaine (Stojanovic, de Prada et al. 2001). In 
addition, the bipartite anti-cocaine and anti-rATP aptamers can reassemble in the 
presence of their cognate analytes (Stojanovic, Prada et al. 2000). Such assays could 
detect PDGF as low as 110 pM PDGF (Fang, Sen et al. 2003) and small molecules at 
micromolars (Stojanovic, Prada et al. 2000; Stojanovic, de Prada et al. 2001).    
Figure 1-1. Folding strategy. (A) Coformational change of the anti-thrombin atpamer. 
The anti-thrombin aptamer is unfolded in the absence of thrombin. The fluorophore 
and quencher are brought together by forming a quadruplex structure in the presence 
of thrombin. (B) Conformational change of the anti-PDGF aptamer. The PDGF 
aptamer is truncated at both termini. In the absence of analyte (grey circle), the two 
ends are destabilized. Upon binding to analyte, the two ends hybridize bringing the 




The more popular engineering scheme for optical structure-switching aptamers is 
to convert from a stable structure to a different binding structure in the presence of 
analyte. In this strategy, the aptamer can be labeled with a fluorescent dye and the 
antisense oligonucleotide with a quencher (Figure 1-2). In the absence of analyte, the 
antisense strand hybridizes with the aptamer and thus quenches the fluorescence. When 
the analyte binds to the aptamer, the antisense oligonucleotide falls apart thus increasing 
fluorescence. Compared to the “folding” strategy, this unfolding strategy may not require 
Figure 1-2. Re-folding strategy. Anstisense sequence (orange) works in cis (A) or in
trans (B) with aptamer (black) to alter the binding conformation. Analyte (grey) 
binding causes the separation of the antisense-aptamer hybrid and leads to 










the knowledge of the secondary or tertiary structures of the selected or to be selected 
aptamers. In addition, this type of assay can be more sensitive because the fluorescence is 
quenched in the absence of analyte and thus the background signal is very low.   
Using such approach an anti-thrombin aptamer beacon was created by adding a 
sequence complementary to a portion of the aptamer to form a nonbinding beacon 
structure in the absence of analyte (Hamaguchi, Ellington et al. 2001). The aptamer and 
antisense strand were labeled with fluorophore and quencher, respectively. Upon binding 
to thrombin the aptamer-antisense duplex separates resulting in increased fluorescence. 
The Kd value of a such designed beacon was 10 nM. Recently, we also generalized this 
strategy for the detections of other analyte such as IgE and PDGF in a chip based format 
(Soderberg, Gullberg et al. 2006).    
Yamamoto et al. combined both “folding” and “refolding” strategies by 
modifying half of anti-HIV-1 aptamer into a hairpin beacon and the bipartite aptamer 
reassembled by Tat (Yamamoto, Baba et al. 2000). In the presence of Tat the beacon 
opens, which leads to fluorescent signals when the hairpin is labeled with a fluorophore 
and its quencher. In the presence of Tat the beacon is opened, resulted in a fluorescence 
signal. Li’s group utilized a trans-acting antisense strand for a series of fluorescent 
structure-switching aptamer designs (Figure 1-2B), where two-piece and three-piece 
aptamer-antisense duplex were constructed for the detection of ATP and thrombin (Nutiu 
and Li 2003; Nutiu and Li 2004). The disassociation of the antisense strand induced by 
analyte binding was reflected by fluorescence increase. Such structure-switching 
aptamers could detect ATP and thrombin with Kd values of 600 µM and 400 nM.  
Moreover, trans-acting fluorescent structure-switching aptamer can also be created by in 
vitro selection (Nutiu and Li 2005). 
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Moreover, the “refolding” strategy has also proven adaptable to detection via 
either electrochemical couples (Xiao, Piorek et al. 2005) or nanoparticle signaling 
strategies (Levy, Cater et al. 2005; Liu and Lu 2005). 
Assisted refolding strategy 
Built on the “refolding” strategy, the analyte-dependent conformational change 
can be assisted by the formation of another duplex structure involving the displaced 
antisense strand. A typical example of “assisted refolding strategy” is the recently 
developed antiswitch, which can detect small molecules by controlling fluorescent 
protein expressions in vivo (Bayer and Smolke 2005) (Figure 1-3). The antiswitch (RNA) 
contains an aptamer domain and an antisense domain. The release of the antisense 
sequence and the ensuing hybridization to a target mRNA sends off signal. Both analyte 
and the 5’UTR of mRNA are required for the structure-switching. The aptamer domain 
binds the small molecule analyte and the antisense domain has a sequence 
complementary to the 5’ end of mRNA to be regulated. For the “off-switch”, the 
antisense domain interacts with the aptamer domain to fomr a hairpin in the absence of 
analyte. Upon binding to analyte, the hairpin structure opens up and the stem of the 
antisense domain becomes single stranded RNA, ready to hybridize to the target mRNA 
and blocks translation. For the “on-switch”, the antisense domain is free to bind to target 
mRNA and suppress gene expression in the absence of analyte. Small molecule binding 
switches back to a hairpin formed by the aptamer domain and the antisense domain, thus 
releasing the target mRNA to rescue the gene expression. 
In this dissertation, we take an approach similar to the “assisted refolding” 
strategy to detect proteins by ligation followed by real-time PCR. The displaced antisense 
strand binds a substrate oligonucleotide to be ready for subsequent ligation. In addition, 
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the antisense region is designed to form a short hairpin structure to enhance the ligation. 
Our design is the first example to adapt structure-switching aptamer for analyte-
dependent ligation and amplification.  
In summary, fluorescent structure-switching aptamers have advantages such as 
versatile signaling, generalizable applications and easy of use. However, they are often 
not very sensitive for diagnostic applications and suffer from high background 
fluorescence caused by impurity of labeled dye, fluorescence quenching in real sample 
matrix and available signal of single labeled fluorophore. On the other hand, to have a 
high signal-to-noise ratio, the non-binding conformation should be very stable by strong 
hybridization between the aptamer and the antisense.  This then requires more energy to 
switch to a binding conformation, and because part of the binding energy is transduced 
into the conformational change the apparent binding constant is increased (less apparent 
affinity). For example, the structure-switching aptamers developed by Nutiu and Li had 
Kd values of 60- and 2-fold reductions of those of the original aptamers (Nutiu and Li 
Figure 1-3. Assisted refolding strategy-antiswitch. In the absence of analyte, the 
antisense domain (red) folds into an “antisense stem”. Analyte binding forces the 
antisense stem open. The displaced antisense domain therefore binds to its target 
transcript and turn the production of target gene (GFP) off.  
GFP
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2003). Future development may find ways to improve affinity reduction, and minimize 
background signals to increase detection sensitivity its dynamic range. With the 
applications of both rational design and in vitro selections, the affinity could be 
increased. Furthermore, the detection sensitivity may be greatly improved by coupling 
nucleic acid amplification techniques. The combination of amplification for aptamer 
based detection does not require sophisticated instruments and allows real-time assay 
with high sensitivity and specificity. Also, when rolling circle amplification (RCA) is 
used for amplification, this technology can be developed into a chip based biosensor.  
Aptazyme 
Analyte-dependent conformational changes can not only be transduced directly 
into optical signals, but into catalysis as well. Advantageous to antibodies, aptamers can 
be inserted into (deoxy)ribozymes to serve as allosteric binding sites. The construction of 
aptazymes takes advantage of the fact that many ribozymes contain stem-loop structures 
that are structurally conserved, but whose sequence can be changed. By introducing 
aptamers in place of these stem-loops, the analyte-dependent conformational changes that 
aptamers normally undergo can potentially be transmitted to the catalytic cores of 
ribozymes, influencing their catalytic activities. To date, various aptazymes capable of 
ligation or cleavage reactions have been either designed or in vitro selected (Table 1-1). 
They can be modulated by analytes such as small molecules, peptides, proteins and 
various metal ions  (Koizumi, Soukup et al. 1999; Soukup and Breaker 1999; Robertson 
and Ellington 2001; Seetharaman, Zivarts et al. 2001; Robertson, Knudsen et al. 2004).  
Like the fluorescent signaling aptamers, aptazymes can also transduce analyte 
recognition into optical signals. For instance, the activity of a hammerhead or hairpin 
aptazyme could be easily read by cleavage of a fluorescent substrate (Figure 1-4A).  
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In addition, same kind of ribozyme could be manipulated to detect different 
analytes, therefore these ribozymes can be arrayed onto a chip to detect multiple analytes 
simultaneously (Seetharaman, Zivarts et al. 2001; Hesselberth, Robertson et al. 2003). 
Our group has assayed combinations of aptazymes that detect small organics, peptides, 
and proteins in parallel (Figure 1-4B; Hesselberth, Robertson et al. 2003). The aptazyme 
substrates were labeled with biotin and the allosteric ribozymes were radioactive. Ligated 
products were retained in streptavidin coated 96-well plates, and unligated materials were 
washed away. The aptazyme ligases in the array could specifically and simultaneously 
detect their cognate analytes, and the limits of detection of the best aptazymes were in the 
nanomolar range. 
An aptazyme has also been used in gold nanoparticle mediated colorimetric 
assays (Liu and Lu 2005). In this case, gold nanoparticles aggregate when the substrate 
oligonucleotide of the adenosine-dependent 8-17 deoxyribozyme binds to the DNA 
oligonucleotide conjugated on the nanoparticles. The nanoparticles turn into blue upon 
aggregation. In the presence of adenosine, the deoxyribozyme is activated and cleaves the 
substrate oligonucleotide. Therefore the nanoparticle aggregates dispel and the solution 
color changes to red. This method detects adenosine form 100 µM to 1 mM.   
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However, aptayzmes usually have higher Kd values compared to the original 
aptamers due to the structure interference of the linked ribozyme. For instance, the Kd
values for anti-protein aptamers are usually at the nanomolar level while a selected L1 
ligase can detect proteins such as Cyt18 and lysozyme at micromolar level (1.5 µM and 
1.3 µM, respectively) (Robertson and Ellington 2001). In another example, the Kd value 
Figure 1-4. Mechanism of signaling aptayzme. (A) A typical cleavage fluorescent 
signaling aptazyme. Cleavage and subsequent dissociation of the substrate lead to the 
separation of a fluorophore from its quencher and increase in fluorescent intensity. (B) 
L1 ligase aptazyme array. Biotin-labeled substrate oligonucleotide and radiolabeled L1 
ligase are used to detect a series of analytes. In the presence of their cognate analytes, 
aptayzme ligation products are immobilized on streptavidin-coated 96-well plates, 
producing a radioactive signal, while unligated aptazymes are washed away. (C) 
Colorimetric aptazyme assay. The substrate strands of the 8-17 DNAzyme hybridizes 
with both the enzyme and the DNA arms conjugated on gold nanoparticles. The 
cleavage activated by adenosine disperses nanoparticles from aggregates (blue circle) to 









of the anti-therophylline aptamer is about 300 nM, while that of the anti-therophylline 
ligase is about 99 µM (Robertson and Ellington 2000). Therefore, this approach can only 
detect analytes at relatively high concentrations. 
Table 1-1. Allosteric (deoxy)ribozymes generated by different strategies. 
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(Levy and Ellington 
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theophylline   Hepatitis delta 
virus (HDV) 
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Activation In vitro selection (Kertsburg and Soukup 
2002) 
adenosine RNA-cleaving 
10-23 and 8-17 
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Activation Rational design (Najafi-Shoushtari and 
Famulok 2005) 
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Coupling aptamer based detections to nucleic acid amplifications  
Proximity (ligation) followed by real-time PCR or RCA 
The combination of immunoassay techniques and nucleic acid amplification using 
antibodies labeled directly with nucleic acids, noted as ImmunoPCR, is very sensitive in 
detecting protein analytes (Adler 2005; Niemeyer, Adler et al. 2005; Barletta 2006), but 
have several distinct disadvantages relative to PCR for the detection of nucleic acids. It is 
difficult to reproducibly prepare antibody-DNA conjugates. Binding and amplification 
reactions must be performed under different reaction conditions, making it difficult to 
develop into a single-tube format; and both specifically and non-specifically bound 
probes can be amplified, potentially leading to high background signals.  
In order to improve the detection sensitivity of immunoassay, various nucleic acid 
amplification technologies are coupled with aptamer based sensors for protein detections. 
Proximity ligation assay (PLA) has achieved a detection limit of 40 zeptomole (10
-21 
mol)
which is equivalent to 1,000-fold improvement over the conventional ELISA 
(Fredriksson, Gullberg et al. 2002). In this assay, a pair of aptamers is brought into 
proximity by binding to PDGF-BB dimer (Figure 1-5A), allowing the extending ends of 
the two aptamer to hybridize to a splint oligoncucleotide. The ensuing ligation and PCR 
enables sensitive detection of the PDGF-BB dimer. Aptamer-PLA is also developed to 
sensitively detect live organisms, such as 100 B.anthracis and 10 B.subtilis spores, and 
down to 1 B.cereus spore (Pai, Ellington et al. 2005). 
In another assay, Di Giusto et al. utilized a pair of aptamers recognizing different 
epitopes of thrombin (Di Giusto, Wlassoff et al. 2005). One of the aptamer serves as a 
primer and the other circular one serves as a template (Figure 1-5B). Thrombin binding 
brings the two aptamers in proximity and triggers the RCA and the amplified product can 
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be monitored in real time. The detection limit for thrombin is about 30 pM, 3-fold lower 
than the Kd value of the anti-thrombin aptamer.  
However, proximity based ligation requires multimeric analyte or multiple 
binding sites on the analyte for the binding of two different aptamers, thus difficult to 
expand to be universally used for any analyte detection.  
Exonuclease protection assay followed by real-time PCR 
Exonuclease protection assay is very similar to nucleic protein assay, where 
analyte binds an aptamer to protect it from nuclease degradation. The undegraded 
aptamers serve as templates for ligation followed by real-time PCR for detection. Wang 
Figure 1-5. Coupling aptamer recognition to nucleic acid amplification. (A) Proximity 
ligation followed by real-time PCR. (B) Proximity extension of anti-thrombin 
aptamer. (C) Exonuclease protection followed by real-time PCR. (D) Analyte binding 










et al. could detect several hundred thrombin molecules by real-time PCR of exonuclease I 
digested thrombin/aptamer mixture (Wang, Li et al. 2005) (Figure 1-5C). This method 
has sensitivity similar to that of PLA. Theoretically, this method should also be 
applicable for other analyte detections. However, no further example has been reported. 
The limitation of this assay is that the incomplete degradation of the excessive free 
aptamer probes, which could lead to false positive or over-estimation of the analytes.  
Hybridization Chain Reaction (HCR) 
HCR is an enzyme-free amplification method alternative to PCR for the rapid 
detection of specific analyte (Dirks and Pierce 2004) (Figure 1-5D). An anti-ATP 
aptamer was used to block the initiator strand in cis by hybridization. ATP binding 
exposes the initiator strand, which triggers a cascade of hybridization between two 
hairpin species to “polymerize” into a nicked double helix.  
RESEARCH OUTLINE
Ligase-based analyses have many attractive features such as high specificity from 
pairwise hybridization to targets and high sensitivity due to amplificable products. In 
addition, assays could be differentiated by inserting a DNA tag during amplification. 
Therefore, our research focuses on the studies of the possibility of gaining in sensitivity 
by signal amplification; and the possibility of using simple antisense methods to 
generally couple aptamers to ligation and signal amplification.  
Previous studies have shown that the structure-switching aptamer can be coupled 
with fluorescent signaling and it is generalizable for both small molecule and protein 
analyte detections. However, it is not known whether the structure-switching aptamers 
can be adapted to ligation and amplification. On the other hand, since modified aptamers 
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or aptazymes usually have lowered affinity with analyte, it would be significant if 
amplification could improve the sensitivity of the detections.  
Coupling amplification with aptazyme based detection 
As we described above, aptazymes usually have limited sensitivities which may 
be improved by product amplification. We have modified an ATP dependent aptazyme 
mediated ligation so that circularized product can be amplified by RCA (Chapter 2; Cho, 
Yang, et al., 2004). Using this strategy, we have successfully detected ATP in both 
solution and also with a chip based assays. The chip based RCA can detect as low as 1 
µM ATP. Such detection limit is lower than the Kd value of the original aptamer (6 µM)
(Huizenga and Szostak, 1995) while binding constants for the unmodified ATP 
dependent ligase are 10 mM and 10 µM (Levy and Ellington 2002). 
Coupling amplification with structure-switching aptamer based detection 
Because nucleic acid secondary structure can be readily ‘programmed’ (Nutiu and 
Li 2003; Bayer and Smolke 2005), we propose to couple conformation-switching 
aptamers using an antisense strategy in a way that leads to ligation and the formation of 
an amplicon for real-time RCA or PCR. We have applied these methods to the well-
known anti-protein aptamers. Our designs differ from the antiswitch strategies with a 
hairpin stem inserted in the displacing sequences. We find that such designed 
conformation-switching aptamers can detect protein analytes sensitively and specifically 
both in solution and in cell lysate. 
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Chapter 2 describes the combination of chip-based RCA with ATP dependent 
aptazyme circularization. The potential of using other aptazyme for ligation and RCA is 
also discussed. Chapter 3 illustrates a protein dependent aptamer circularization followed 
by real-time RCA for the detection of protein analyte. Chapter 4 describes coupling 
Figure 1-6. Research outline: analyte-activated ligation followed by amplification.
Analyte is represented in red. Aptamer or aptamer domain is labeled in black. (A) 
Aptazyme ligase mediated ligation followed by chip based RCA. In the presence of 
analyte, the padlock probe is ligated into a circle by the aptazyme ligase. The ligase 
also serves as a primer for amplification of the circular probe. (B, C, D) Structure-
switching aptamer-mediated ligation followed by real-time amplifications. These 
structure-switching aptamers are designed based on an antisense strategy. An antisense 
sequence (red) binding to the aptamer disrupts the binding conformation. In the 
presence of protein analyte, the displaced antisense strand forms into a short hairpin 
which subsequently binds to a substrate strand for ligation. The ligated product is 













structure-switching aptamer with four- and three-piece ligations followed by real-time 
PCR for the detection of protein analyte, which also serves the guidance for the assay 
designed in Chapters 3 and 5. Chapter 5 reports the further improvement of structure-
switching aptamer coupled with ligation and real-time PCR. The final assay of two-piece 
ligation and real-time PCR is capable of detecting proteins in general with high 
sensitivity and ease of use.  
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Chapter 2:  Using a deoxyribozyme ligase and rolling circle 
amplification to detect ATP 
INTRODUCTION
Since the Breaker group initially joined an aptamer with a nucleic acid enzyme to 
generate the allosteric ribozyme, the so called aptazyme (Tang and Breaker 1997), RNA 
or DNA aptamers have been adopted for allosteric ribozymes or deoxyribozymes (Yang 
and Ellington 2006). The resultant aptazymes have two domains: the aptamer binding 
domain and an enzymatic domain. The aptamer binding domain changes its conformation 
upon binding to its cognate analyte so as to switch on or turn off the activity of the 
catalytic domain. Majority of the generated aptazymes are those capable of either 
cleavage or ligation. Such aptazymes have been rationally designed or in vitro selected to 
detect analytes such as ATP, FMN, theophylline, peptide and protein analytes. 
Aptazyme-based chip arrays have also been performed to detect multiple analytes 
(Seetharaman, Zivarts et al. 2001; Hesselberth, Robertson et al. 2003). The unique 
property of the aptazyme ligase is that they can convert the recognition of analytes into 
the production of amplicons, which would allow rapid and robust detections using 
amplification techniques.  
Rolling circle amplification (RCA) was first observed in bacteriophage 
replication. And it was found that single-stranded circular DNA can also serve as a RCA 
template for DNA polymerase to generate numerous concatemerized product 
(Daubendiek and Kool 1997). Moreover, Eric Kool’s lab has generated small circular 
substrates with 26-74 nucleotides (nt) in lengths, which can serve as efficient RCA 
templates for several DNA polymerase enzymes in vitro (Kool 1996). In RCA, a small 
nucleic acid circle hybridizes to a primer, which is in turn extended around the circle, 
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ultimately displacing the original primer and continuing to produce long nucleic acid 
product. Phi29 DNA polymerase which is highly processive is often used in RCA. It has 
exceptional strand displacement ability and it can also maintain the polymerization 
reaction for as least 12 hours (Baner, Nilsson et al. 1998).  
RCA has been used for detection of both DNA and RNA either in solution 
(Faruqi, Hosono et al. 2001; Zhang, Zhang et al. 2001; Rector, Tachezy et al. 2004) or in
situ (Zhou, Calciano et al. 2001) and the latter has been accomplished at single cell level 
(Christian, Pattee et al. 2001). RCA has been an especially useful process for surface-
Figure 2-1. Schematic representation of surface RCA for protein and nucleic acid 
detections. (A) An RCA primer is tagged on an antibody, which binds to a protein 
immobilized on the surface. Unbound antibodies are washed away. Bound antibodies 
are detected by extension of the primers around the circular probes. (B) Nucleic acid 
target is immobilized on a surface. Both the 5’ and 3’ termini of the padlock probe are 
complementary to the target. DNA ligase circularizes the padlock probe and the target 
DNA serves as a primer for RCA. (C) The RCA primer is immobilized on the surface. 
In the presence of target nucleic acid, the padlock probe is circularized, and the 
immobilized primer is extended by the polymerase in a RCA reaction. (D) 
Immobilization of the primer dependent on ligation. In the presence of nucleic acid 
target, the primer used for RCA is ligated to the oligonucleotide attached on the 
surface. Therefore, RCA product is deposited on the surface. 
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based signal amplification because RCA products are deposited and remain localized at 
the surface spot. In addition, the isothermal conditions are easily operated on chips. Chip-
based RCA has been developed for both nucleic acid and protein detections (Lizardi, 
Huang et al. 1998; Hatch, Sano et al. 1999; Schweitzer, Wiltshire et al. 2000; Nallur, Luo 
et al. 2001; Schweitzer, Roberts et al. 2002; Zhou, Bouwman et al. 2004; Soderberg, 
Gullberg et al. 2006). By far, RCA protein chips (Figure 2-1A) have been profiled to 
hundreds of proteins and extensively used for diagnostics, high throughput screening, 
expression proteomic applications and clinical biomarker discovery (Kingsmore and 
Patel 2003). Moreover, it has also been demonstrated that RCA can effectively screen 
mutant nucleic acid targets using a solid-phase format under different strategies (Figure 
2-2B, C, D) (Lizardi, Huang et al. 1998; Hatch, Sano et al. 1999). However, only few 
chip-based RCA has been reported for the detection of small molecules. 
Currently, the cleavage or ligation reactions catalyzed by aptazymes are usually 
detected by gel assays or fluorescent assays which are not very sensitive. On the other 
hand, aptazymes usually have decreased detection limits compared to the selected 
aptamers probably because increased free energy required to drive a conformational 
transition in the catalytic core of the aptazyme. Therefore, it would be extremely useful to 
harness aptazymes for amplification of a nascent binding and ligation signal. On the other 




C, which makes the adaptation of aptamer based sensing to 
chip-based RCA desirable. Based on these points above, we propose to couple chip-based 
RCA with aptazyme mediated analyte-activated ligations.  
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To address this goal, we carried out modification of an ATP dependent 
deoxyribozyme ligation, which was previously created in our lab by appending the anti-
ATP aptamer to a selected deoxyribozyme ligase (Levy and Ellington 2002). This 
deoxyribozyme ligase catalyzes the autoligation of a 3’-phophorothiate onto a 5-iodine 
residue, and ligation activity is activated up to 250-fold in the presence of 10 mM ATP 
(Figure 2-2). We designed the substrate of this aptazyme into a padlock probe that could 
Finger 2-2. The ATP-dependent ligation by deoxyribozyme ligase. (A) The 
iodinophosphorothiote-reaction producing the linkage between two linear substrates 
(from Dr. Matthew Levy's dissertation (Levy 2003)). (B) ATP-dependent ligase 
together with substrate oligonucleotide (Levy and Ellington 2002). This aptazyme has 
250-fold activation upon ATP recognition.  

















































be ligated into a circle in the presence of ATP. Since the 3’ end of the aptazyme anneals 
to the padlock probe, the immobilized aptazyme also serves as a primer for chip-based 
RCA.
RESULTS AND DISCUSSION 
Design of the padlock probe  
In order to generate circular ligation products, we modified the substrates for 
ligation. The original ATP-dependent aptazyme ligase was created by appending the anti-
ATP aptamer to a selected deoxyribozyme (Figure 2-2B). In the presence of ATP, the 5’ 
and 3’ ends of the two substrate oligonucleotides are juxtaposed, and joined by a 
phosphorothiate-iodine linkage (Figure 2-2A). To generate circular ligation product, a 
linker sequence was introduced to connect the two substrate strands resulting in a padlock 
probe. As an initial test, we designed four padlock probes with different linker lengths as 
shown in Figure 2-3. The linker CT rich region was chosen to prevent any secondary 
structure that might interfere with ligase binding site. Some G and A bases in the linkers 
were to form a short hairpin with some of the C and T bases; thus bringing one end close 
to the other and stabilize the structure of the linker. The secondary structure of the 
redesigned padlock probe was confirmed by MFOLD 
(http://www.bioinfo.rpi.edu/applications/mfold/old/dna). The lengths of these four 
padlock probes were 43, 56, 58 and 63 nt, respectively. We tested the ligation activities 
of the aptazyme using these probes in the absence or presence of 10 mM ATP. Ligation 
signals were generated by all of these above substrates as soon as 5 min in the presence 
of ATP but not in the absence. Even when incubated up to 1 h, these aptazymes 
demonstrated strong ATP preference, and ligation product with ATP was significantly 
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more than that without ATP. However, if the incubation time was longer than 2 hr, the 
background ligation level accumulated significantly (Figure 2-4). After 2 h ligation 
incubation, the 63 nt padlock probe (Sub.63) demonstrated the highest signal-to-noise 
ratio among all the designed padlock probes. Therefore, we chose Sub.63 to carry out the 
following ligation and amplification assays.  
Figure 2-3. Designed padlock probes were derived from the two linear substrates of 
the ATP-dependent aptazyme. (A) A padlock probe was created by connecting the 
substrate recognition sites (brown and green) via a linker strand (blue). Therefore the 
ligated product by aptazyme (black) is a circular probe. (B) Linker sequences of the 
designed padlock probes. 


























































Optimization of ligation in solution 
To find out monovalent cation’s effect on ligation activation, we performed 
assays with 500 mM NaCl. This concentration of NaCl was also present in the 
deoxyribozyme ligase selection buffer (Levy and Ellington, 2002). Since our final goal is 
to carry out chip-based RCA, in order to determine the affect of NaCl on chip-based 
assays both biotinylated and unmodified aptazymes were assayed for ATP activated 
ligations.  In these assays, Sub.63 and the aptazyme were mixed at 25 
o
C and ligation 
was carried out either in the presence or in the absence of 10 mM ATP. Aliquots of the 
terminated ligation reactions were taken after different incubation time. Ligated and 
unligated probes were separated using a denaturing 8 % polyacrylamide gel and 
Figure 2-4. Ligation assays using designed padlock probes. Ligations were carried out 
in the presence or absence of 10 mM ATP for 2 h. Ligated and unligated padlock 
probes (Sub.43, Sub.56, Sub.58 and Sub.63) were separated by 8 % PAGE. M 
represents a 10 bp DNA ladder. Apt stands for reactions containing only aptamers.  
padlock probe     43        56         58          63





visualized by SYBR Gold staining. The results are presented in Figure 2-5. Both assays 
with and without NaCl demonstrated ATP activation. At 30 min ligation, for both 
biotinylated and unmodified aptazymes the extent of ATP activation in the presence of 
NaCl was comparable to that obtained without NaCl. However, when ligation time was 
extended to 60 min, NaCl caused the increase of background ligation of biotinylated 
aptazyme while the unmodified aptazyme behaved in the same way both in the presence 
and absence of NaCl (Figure 2-5).   
Figure 2-5. The effect of NaCl on ligation. Ligations with or without 10mM ATP 
were carried out using biotin-labeled and unmodified aptazymes with padlock probe 
Sub.63 in the presence or absence of 500 mM NaCl. Ligations were determinated at 





































Previous studies have reported that the immobilization of aptamers and aptazymes 
onto solid substrates altered their target-binding and kinetic characteristics (Seetharaman, 
Zivarts et al. 2001; Kirby, Cho et al. 2004); therefore, it was possible this would occur for 
the deoxyribozyme ligase as well. In concerning of the applicability of chip-based RCA, 
additional biotinylated aptamers with different liners (dT and T10) were also constructed 
in order to tether the aptazymes to chip surfaces. These linkers locate at the 5’ ends that 
would extend them away from the surface. Unmodified, biotin-, biotin-dT and biotin-T10 
labeled aptazymes were assayed with the Sub.63. Using the NaCl-free ligation buffer, 
ligation signals were monitored as a function of time (Figure 2-6). All four aptazymes 
showed strong ATP preferences over the whole time course. The biotin-aptazymes 
demonstrated a slightly higher extent of ligation (40-42 %) compared with unmodified 
aptazymes (34 %) in the presence of ATP, but they also showed a significant increase in 
background ligation in the absence of ATP (14-24 % of ligation for biotin-labeled 
aptazymes vs 6 % ligation for unmodified aptazyme). As a result, the ligation activation 
(ratio of percent ligation in the presence of ATP vs percent ligation in the absence of 
ATP) for the biotin-labeled aptazymes was between 1.7 and 4.7, whereas the ligation 
activation for the unmodified aptazyme was 7.0. Interestingly, the catalytic activity of 
Figure 2-6. Time course monitoring of ligation activation for labeled and unlabeled 
aptazymes in solution. (A) PAGE images of ligation activities. (B) Kinetic analyses of 
aptazymes (a), biotinlabeled aptazyme (b), biotin-dT-labeled aptazyme (c), and biotin-
T10-labeled aptazyme (d), respectively. Black lines represent % ligation in the 
presence of ATP, black dotted lines represent % ligation in the absence of ATP, and 
red line represents ligation activity (ratio of % ligation in the presence of ATP vs % 
ligation in the absence of ATP). 
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biotin-labeled aptayzmes decreased by about 32-64 % by adding linkers such as dT and 
T10.
However, the ligation activation levels observed here are much lower than that 
(~250-fold) of the unmodified ATP dependent aptazyme (Levy and Ellington, 2002).  
The increased background ligation may be explained by the shortened distance between 
the two substrate binding sites. The change from intermolecular to intramolecular 
distance would facilitate the hybridization between the aptazyme and the padlock probe.  
Figure 2-7. Amplification of ATP-dependent ligation activities using fluorescent 
dCTP. Ligation was carried out for 1 h followed by RCA for various time periods (0, 
5, 10 and 15 min, respectively). (+) and (-) represent the presence and absence of 10 
mM ATP, respectively. RCA product, circularized padlock probe, unligated padlock 
probe and aptazyme were separated by an 8 % PAGE gel. M represents a 10-bp DNA 
ladder.
0min     5min    10min     15min






RCA using fluorescent dCTP 
The advantage of direct incorporation of fluorescent dNTPs in an RCA product is 
that the product could be directly visible in gel and surface assays and would not require 
future staining or labeling. Therefore, we tested the feasibility of RCA using fluorescent 
dCTP. Because the 3’ end of the aptazyme was completely complementary to the 
substrates, we simply used the aptazyme as an RCA primer for amplification.  
Ligation was carried out for 1 h. Aliquots of the terminated ligation mixture were 
transferred into an RCA reaction containing 10 mM dCTP, 0.15 mM F-dCTP (F=Alexa 
Fluor 488-7-OBEA) and 0.25 mM each of the other dNTPs. RCA was performed at 37
 o
C
for 5, 10 and 15 min and stopped by heating at 65
 o
C for 3min. Amplified product was 
assayed by gel electrophoresis without any additional staining. However, the fluorescence 
amplification signals in the gel image (Figure 2-7) were much weaker than those obtained 
by amplification using unlabeled dNTPs and staining with SYBR Gold (Figure 2-8). This 
may indicate that amplification using fluorescent dCTP was not as efficient as that using 
regular dCTP. Furthermore, this may suggest that F-dCTP was not compatible with phi29 
polymerase. Due to the reduced amplification caused by F-dCTP, all the following RCA 
reactions were carried out using unlabeled dNTP. Therefore, RCA product in solution 
were examined by PAGE stained by SYBR Gold, and RCA on surface was visualized by 
hybridization with Cy3-labeled probe oligonucleotides.     
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RCA in solution 
The aliquots of ligations using unlabeled aptazymes were taken after 1 h, ligated 
products were directly amplified without further purification by using the phi29 DNA 
polymerase at 37 
o
C, and the amplification mixtures were separated by gel 
electrophoresis (Figure 2-8). The signal due to RCA increased approximately 1500-fold 
after 10 min of amplification. The signal in the presence of ATP was about 19-fold higher 
than in the absence of ATP. Biotin-labeled aptazyme was also tested with the 5 min 
Figure 2-8. Unlabeled aptazyme-mediated ATP-dependent ligation followed by RCA 
in solution. (A) Analysis of RCA product by gel electrophoresis. (+) and (-) represent 
the presence and absence of 10 mM ATP, respectively. Ligations were carried out for 
1h, followed by RCA for various time periods (0, 5, 10 and 15 min). RCA product, 
circularized padlock probe, unligated padlock probe and aptazyme are indicated. M is 
a 10 bp DNA ladder. (B) Quantitative analysis of RCA product as a function of RCA 
time. Black lines represent % ligation in the presence of ATP, black dotted lines 
represent % ligation in the absence of ATP, and red lines represent amplified ligation 









ligation product used for RCA at 10, 20 and 30 min (Figure 2-9). Again, the activation 
was about 33-fold by ATP, which was much lower than previously reported (250-fold, 
Levy and Ellington, 2002), likely because the amplification provided by RCA 
overrepresented the background ligation reaction. Even without optimization of the 
ligation and RCA reactions, the positive signal was clearly detectable when compared to 
the negative control. Additionally, these results suggested the potential for analyte 
quantitation in a multiplexed format.  
Figure 2-9. Biotin-labeled aptazyme-mediated ATP-dependent ligation followed by 
RCA in solution. (A) Gel images of RCA activities. Ligation and RCA were carried 
out using biotin-labeled aptazyme as descibed in Figure 2-7. RCA was carried out for 
10 min, 20 min and 30 min, respectively. (B) Quantitative analysis of RCA product as 

































































Chip-based RCA assay 
This novel assay strategy could be readily applied to a chip array format (Figure 
2-10). As a chip-based immunoRCA assay, the amplified product would be localized 
within the spots on arrays. Aside from its better applicability, the chip array has other 
advantages: we had noticed that the background in solution RCA was high, probably due 
to the fact that ligation could not be stopped prior to RCA. Because an array assay would 
allow washing and removal of the unligated padlock probe and the analyte, ATP, 
presumably generating lower background compared with solution assays.  
Figure 2-10. Schematic drawing of aptamer-mediated chip-based RCA. The biotin- 
aptazymes are immobilized on streptavidin-coated glass slides. Ligations are carried 
out in the presence (A) and absence (B) of ATP. RCA is initiated from the 3’ end of 
the aptazyme, and the extended aptazymes are visualized by hybridization with Cy3-
labeled complementary oligonucleotides (green circle). Aptazymes bound to 
circularized padlock probes generate long concatemers RCA product (A) and 




Next, we prepared chip arrays by printing biotin-labeled aptazymes. Printed 
aptazymes were incubated at room temperature for 1 h under high humidity (60-80 %) to 
allow better binding of streptavidin and biotin and then exposed to either 10 mM or 0 
mM ATP. Initially, we tried 1 µM aptazyme for printing; however, the amplification 
signal was so strong that fluorescence quenched in the center of the spots (data not 
shown). Instead, using 0.1 µM aptazyme printing, no signal saturation was found while 
the fluorescence was still high enough. Additionally, reducing padlock probe 
concentration resulted in decreased ATP activation (ATP+/- signal ratio). As a result of 
optimization in chip-based assays, the same padlock probe concentration and one tenth of 
the aptazyme concentration were used as compared with these concentrations in solution.  
After 10-90 min ligation, slides were washed with ligation buffer (50 mM Tris-Cl 
buffer, pH 7.4, and 50 mM MgCl2) containing 0.05 % Tween 20. Ligated products were 
amplified by RCA at 37 °C for 5 min, and the slides were again washed twice with SSC 
buffer containing 0.05 % Tween 20. Finally, amplified products were detected by 
hybridization with 0.5 µM complementary, fluorescent oligonucleotide probes at 37 °C 
for 30 min. Fluorescent spots were visualized using an Axon Instruments (Union City, 
CA) 4000B confocal microarray scanner. The fluorescence intensity at excitation of 532 
nm was analyzed using GenePix 4.1 software (Axon Lavoratory). Figure 2-11 showes the 
fluorescence images of biotin-modified aptazyme spots when they were subjected to 
various ligation times. A 60 min ligation followed by 5 min RCA demonstrated the 
highest activation (~62-fold) upon ATP recognition.   
 36
Figure 2-11. Effects of varied ligation timeperiods on amplification signals in chip-
based assays. (A)  Fluorescent images of amplified ATP activation. Ligations were 
carried out in the presence or absence of 10 mM ATP for different time periods and 
then followed by 5 min RCA. Amplifications were visualized by hybridization with 
Cy3-labeled complementary probes. (B) Analysis of fluorescence intensity and ATP 
activation of those shown in (A).  
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Figure 2-12. Effects of varied RCA timeperiods on amplification signals in chip-
based assays. (A) Fluorescent images of amplified ATP activation. Ligations were 
carried out in the presence or absence of 10 mM ATP for 10 min, and then followed 
by RCA for different time periods. (B) Quantitation of fluorescence intensity and ATP 
activation.
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Figure 2-13. Detection specificity of chip-based RCA. (A) Fluorescence images of 
amplified ligation activities using biotin-lableled aptazymes with various linkers on 
chip arrays showing the specificities over various nucleotides. (B) Amplified ligation 
activity measured in the presence of NTPs (10 mM ATP, UTP, GTP and CTP) and in 
the absence of NTPs (denoted as control) for biotin-modified aptazymes with various 
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Figure 2-14. ATP-sensing performance on a chip array. (A) Fluorescence images of 
biotin-aptazyme (I), biotin-dT-aptazyme (II) and biotin-T10-aptazyme (III) spots on a 
chip array at various ATP concentrations. (B) Amplified ligation activity as a function 
of ATP concentration for biotin-modified aptazymes with various linkers: no linker, 
dT, and T10. The dotted line represents the best fit to the Hill equation (SigmaPlot, 
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Similarly, ligation was carried out for 10 min followed by RCA for 5-80 min 
(Figure 2-12). Though high activation (~45-fold) was seen with 20-40 min RCA, this 
value was still below the activation achieved by 60 min ligation coupled with 5 min RCA 
(~62-fold). So the final optimal conditions for chip-based RCA were 60 min ligation 
followed by 5 min RCA. 
Using the optimized conditions, amplified ATP activation was examined by 
printing biotin-modified aptazymes with and without linkers. Printed aptazymes were 
processed as described previously and then exposed to either 10 mM ATP, UTP, CTP, or 
GTP. After 1 h ligation, slides were washed with ligation buffer to remove unbound 
NTPs and unligated padlock probes. Ligated padlock probes were amplified by phi29 
polymerase at 37 °C for 5 min. After termination of RCA by washing out RCA reagents, 
amplified products were detected by hybridization with 0.5 µM complementary, 
fluorescent oligonucleotide probes at 37 °C for 30 min. Figure 2-13A shows the 
fluorescence images of biotin-modified aptazyme spots when they were subjected to 
various nucleotides. Even though the images were taken at relatively low excitation 
power (PMT power of 400V at ex 532 nm), bright signals due to signal amplification 
using RCA (~13-fold) could readily be seen.  
Figure 2-13B summarizes the amplified ligation activities for three biotin-
modified aptazymes with various linkers. In general, the aptazyme without a linker 
showed higher activation than aptazymes containing linkers, as was the case in solution. 
However, all aptazymes exhibited more than 100-fold activation in the presence of ATP 
and showed no or very weak activation (<5 %) above background by other NTPs. The 
improved responsivity on the surface relative to that in solution could be attributed in part 
to the fact that unreacted, linear substrate could be washed away prior to initiating RCA 
and was therefore unable to react further during the amplification step. These results 
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demonstrate that aptazyme-catalyzed effector-dependent ligation coupled with RCA can 
differentiate between structurally similar molecules such as UTP, CTP, and GTP on a 
sensor platform with a preparation time of an hour and a development time of only a few 
minutes.  
Finally, to determine if a combination of aptazyme-catalyzed ligation and RCA 
could be used to quantitate analytes in the chip array format, response curves were 
obtained by measuring the fluorescence intensity of RCA products as a function of ATP 
concentration. Responses were measured for all three ATP responsive deoxyribozyme 
ligase aptazymes with different linker sequences. Figure 2-14A shows the scanned 
images of fluorescently-labeled aptazyme-catalyzed circularization and RCA reactions as 
a function of ATP concentration. The biotinylated aptazyme without any linker again 
yielded the best responsivity (Figure 2-14B). As previously reported, the anti-ATP 
aptamer has two ATP binding sites, which seem to function cooperatively (Levy and 
Ellington, 2002; Jhaveri, Kirby, et al., 2000). Therefore, the sharpness of the sigmoidial 
response curve is not surprising. The calculated Hill coefficient for the biotin-labeled 
aptazyme was 2.1± 0.56. While as little as 1 µM ATP could be reproducibly detected by 
the deoxryibozyme ligase, a large response was produced over a relatively narrow 
concentration range (from 10 to 100 µM). The deoxyribozyme essentially serves as a 
“switch” that activates amplification only at a threshold concentration of ATP. Selected 
aptazymes that we and others have reported have lower background rates of ligation and 
thus might give better limits of detection. In addition, the fact that the assay takes places 
directly on a chip surface in the presence of a very small amount of aptazyme (ca. 300 
amol) may make it possible to prevent the dilution of cellular metabolites into large 
volumes, as is the case for many conventional, enzyme-based assays. 
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CONCLUSIONS
We have described a novel analytical approach in which analytes are transduced 
into amplicons, in this case circular probes that could be readily amplified by rolling 
circle amplification. The utility of this strategy has been demonstrated for the sensitive 
detection of ATP. Aptazyme-coupled RCA was adapted to a sensor platform that could 
be easily read and multiplexed, and reproducible signals were acquired within a few 
minutes. 
FUTURE PLANS
As we described previously, many aptazymes have been created to be modulated 
by analytes. However, among them only a few are deoxyribozymes. In order to use more 
aptazymes to couple with nucleic acid amplification, the future directions might be the 
development of more DNA aptazymes by either rational design or in vitro selection and 
the use of RNA aptazyme for this purpose. The development of the former may directly 
generate amplicons. However, the latter may need different strategies for the purpose of 
amplification. 
For RNA aptazyme ligases, the most direct way is to use real-time RT-PCR for 
the detection of analyte-dependent ligations. For example, the L1 ligase could ligate itself 
to another RNA oligonucleotide upon interaction with either small molecule or proteins. 
Therefore, real-time RT-PCR should be able to detect the ligations caused by analyte 
binding.
Besides generating ligation product in the presence of analyte, production of a 
primer could be another configuration for coupling aptazyme activity to RCA. Recently, 
Jonstrup et al. have reported that detection of miRNA using RCA (Jonstrup, Koch et al. 
2006). In this instance, the padlock probes anneal to the miRNA and are subsequently 
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ligated by DNA ligase. MiRNA then serves as a primer for RCA. This result 
demonstrated the feasibility to use RNA as primers for RCA. Therefore, similar strategy 
as Figure 2-1D might be suitable for chip-based RCA using the RNA aptazyme such as 
L1 ligase. The substrate oligonucleotide of L1 ligase can be immobilized on microarray 
slides and the 3’ sequence of L1 ligase can serve as a primer for RCA. In the presence of 
analyte, L1 ligase is ligated to the substrate strand and retained on surface. With 
additional circular template and polymerase, the ligated species can be amplified. 
However, the unligated species must be removed by washing prior to amplification.  
RNA aptazyme capable of analyte-dependent cleavage can also be modified to 
generate a primer for amplification. For example, the 5’ end of substrate strand of the 
allosteric hammerhead ribozyme can be immobilized and the other end can be modified 
with a 3’ terminator base such as ddC to block amplification. So when there is analyte 
dependent cleavage, the substrate is cleaved and the new 3’ terminal can hybridize to a 
circular DNA for amplification.   
With the development of multiple configurations of coupling aptazyme activity 
with signal amplification, more aptayme biosensors could be generated and should be 
especially useful for the detection of both small molecules and proteins.  
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The designed padlock probes were synthesized in our laboratory on an Expedite 
8909DNA synthesizer (PE Biosystems, Foster City, CA) via standard phosphoramidite 
chemistry using synthesis reagents purchased from Glen Research (Sterling, Virginia). 
The sequences of the padlock probes are shown in Figure 2-3. They all contain 5’-iodine 
and 3’-phosphorothioate. The 3’ phosphorothioates were synthesized on 3’ phosphate-
CPG by replacing the normal oxidizing reagent with the sulfurizing reagent thiosulfonate. 
The 5’ I-dT of synthesized oligonucleotides were deprotected in NH4OH at room 
temperature for 24 h followed by purification by denaturing polyacrylamide gel in the 
presence of 7 M urea prior to use. 
The following oligonucleotides were purchased from IDT (Coralville, IA). 
Aptazymes with different modifications at the 5’ end, including aptazyme, biotin-
aptazyme, biotin-dT-aptazyme and biotin-T10-aptazyme, have the same sequences (5’-
CGAAGACAGGTTCCTGGGGGAGTATTGCGGAGGAAGGTGC). F-probe 
(fluorescent oligonucleotide probe: 5’-Cy3-GTTTTCGCCTTCTTGTTTCC-3’) contains 
complementary sequence to the RCA product.   
Ligation assay in solution. 
Ligation reactions were carried out at room temperature in a 20µL reaction 
volume. 15 µL pre-ligation mixture containing 0.5 µM aptazyme/biotin-aptazyme/biotin-
dT-aptazyme/biotin-T10-aptazyme, 50 mM Tris-HCl (PH. 7.4), 50 mM MgCl2, 0.5 M 
NaCl was heated at 70 
o
C for 3 min. Then 1 µL of 20 µM padlock probe, 2 µL of 20 µM
DTT, 2 µL of 100 mM ATP or H2O was added to the pre-ligation mixture. Ligtation 
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reactions were incubated at room temperature for different time periods and then 
terminated by addition of 95 % formamide gel-loading buffer. Ligated (circular) and 
unligated (linear) padlock probes were separated by denaturing 8-10 % acrylamide gels 
containing 7 M urea followed by SYBR-Gold (Molecular Probe, Eugene, OR) staining at 
room temperature for 5 min. The fluorescent bands were visualized either by a UV 
illuminator or a fluorescent scanner (Biorad, Hercules, CA). The fluorescence intensity of 
DNA bands was quantitated using ImageQuant 5.2 software (Molecular Dynamics, 
Sunnyvale, CA). 
RCA in solution 
RCA reactions were prepared by mixing aliquots of 4 µL of the ligation mixture, 
2 µL of 10x phi29 buffer (400 mM Tris-HCl, 500 mM KCl, 100 mM MgCl2, 50 mM 
(NH4)2SO4, 40 mM DTT), 2 µL of 10x dNTP (2.5 mM), 3 µL of phi29 polymerase (10 
ng/µL) (Epicenture, Madison, WI) and 10 µL H2O. Reactions were performed at 37
 o
C
for 5-120 min and stopped by heating in 47.5 % formamide gel-loading buffer at 65 
o
C
for 10 min. Electrophoresis analysis of RCA was carried out by either 8 % or 10 % 
denatured polyacrylamide gels, which were then stained with SYBR Gold, and the bands 
were quantitated. 
Ligation reactions on streptavidin coated glass slides 
The streptavidin-coated microarray slides were purchased from Pierce 
Biotechnology (Rockford, IL). Pre-ligation mixture containing 0.1 µM either biotin-
aptazyme, biotin-T10-aptazyme or biotin-dT-aptazyme were denatured at 70 
o
C for 3 min 
and cooled to room temperature prior to printing. Then glycerol was added to these 
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aptazymes to obtain 5 % final concentration. Aptazymes were printed using a manual 
arrayer (V&P Scientific, Inc., San Diego, CA) within a 60-80 % humidity chamber. The 
slides were incubated in the same chamber at room temperature for 1 h after printing to 
allow biotinylated moieties of the aptazymes to be bound to the streptavidin coating on 
the slides. Then the printed areas were enclosed within a CoverWell incubation chamber 
with self-adhesive rubber gasket for 4 wells (Schleicher and Schuell, Keene, NH). 1 mL 
of ligation buffer containing 0.05 % Tween 20 was pipetted into each chamber through 
access ports that were sealed to remove unbound aptazymes. Ligation was carried out 
using 70 µL substrate mixture (1.0 µM padlock probe, 50 mM Tris-HCl, 50 mM MgCl2,
0.5 mM DTT) with different ATP concentrations (0-10 mM) for individual chambers. 
Ligation reaction was stopped by washing the chamber using 1x ligation buffer plus 0.05 
% Tween-20. 
RCA reactions on streptavidin coated glass slides 
RCA was carried out using 70 µL RCA buffer (40 mM Tris-HCl (pH 7.5), 50 mM 
KCl, 10 mM MgCl2, 5 mM (NH4)2SO4, 4 mM DTT, 0.25 mM dNTP, 0.2 mg/µL BSA) 
with 2 ng/µL phi29 polymerase in each chamber. The reactions were incubated at 37 
o
C
for 5-120 min and then terminated by washing the chamber with 2x SSC (300 mM 
sodium chloride and 30 mM sodium citrate) containing 0.05 % Tween 20. Then 70 µL
hybridization buffer (2x SSC with 0.05 % Tween-20) containing 0.5 µM Cy3-probes 
were applied to each chamber for hybridization with the RCA product at 37 
o
C for 30 
min. Finally, covers of the chambers were peeled away and the slides were washed twice 
using 2x SSC/0.05 % Tween-20 for 10 min, twice with 1x SSC/0.05 Tween-20 for 10 
min, and once with 0.5x SSC for 20 min. The slides were dried by centrifuging at 600 
rpm at 25 
o
C for 5 min. Slides were scanned on an Axon Instruments (Union City, CA) 
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4000B confocal microarray scanner. The photomultiplier tube (PMT) voltage for 532 nm 
(CY3) and 635 nm (CY5) were 400 and 650 volts, respectively. The fluorescence 
intensities at excitation of 532 nm were analyzed using GenePix 4.1 software (Axon 
Lavoratory).
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Chapter 3:  Real-time rolling circle amplification (RCA) for protein 
detection
INTRODUCTION 
Real-time PCR is now the method of choice for many diagnostic applications 
(Barletta 2006; Espy, Uhl et al. 2006; Watzinger, Ebner et al. 2006). However, it is 
difficult to adapt real-time amplification to the detection of protein (rather than nucleic 
acid) analytes.  
RCA is instead being adapted to the detection of proteins (Schweitzer, Wiltshire 
et al. 2000; Schweitzer, Roberts et al. 2002; Zhou, Bouwman et al. 2004; Di Giusto, 
Wlassoff et al. 2005; Soderberg, Gullberg et al. 2006). In RCA, a small nucleic acid 
circle hybridizes to a primer, which is in turn extended around the circle, ultimately 
displacing the original primer and continuing to produce long concatameric nucleic acid 
products. The nucleic acid products can be detected by a variety of methods, including 
hybridization of fluorescent oligonucleotide probes. Interestingly, the concatamers are so 
massive that they can accumulate and be detected as discrete single molecules on 
surfaces (Lizardi, Huang et al. 1998; Schweitzer, Wiltshire et al. 2000; Nallur, Luo et al. 
2001; Schweitzer, Roberts et al. 2002; Zhou, Bouwman et al. 2004; Cho, Yang et al. 
2005).
It has recently proven possible to carry out real-time RCA reactions using 
strategies similar to those for real-time PCR detection, such as detection of newly 
synthesized products with molecular beacons, cleavable probes, or SYBR Green 
(Nilsson, Gullberg et al. 2002; Harvey, Lee et al. 2004; Smolina, Demidov et al. 2004; Di 
Giusto, Wlassoff et al. 2005; Yi, Zhang et al. 2006). Because of the advantages inherent 
in using real-time methods to quantitate amplification reactions, it would be extremely 
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advantageous to be able to adapt RCA for the detection of proteins to real-time methods. 
However, it is not immediately obvious how this might be done, given that real-time 
reactions are not routinely carried out on surfaces and that the capture of circular 
templates by protein ligands must be separated in time from RCA itself. 
The most current method for RCA detection of proteins typically involves linking 
an oligonucleotide to an antibody, binding the conjugate to an immobilized protein target, 
washing away unbound antibodies, and carrying out RCA for detection of the bound 
conjugates. In chip-based methods, a sandwich assay is typically used, and several 
secondary antibodies may be added prior to RCA. These methods are time-consuming, 
expensive, cumbersome, and far from real-time. 
We propose to combine real-time RCA with protein detections using aptamers. A 
real-time RCA assay for the detection of protein analytes would not only be fast and 
quantitative but could also potentially be carried out in heterogeneous solutions without 
having to wash away unbound affinity reagents or DNA templates. In order to combine 
these two techniques, we will catalyze the formation of circular RCA templates by 
protein analytes rather than by hybridizing nucleic acid analytes. The vehicle for the 
protein-dependent formation of circular templates will be structure-switching nucleic acid 
aptamers. Aptamers are single-stranded DNA and RNA molecules selected in vitro from 
random sequence libraries. Aptamers have been selected against a variety of analytes, 
including inorganic ions, small organics, metabolites, peptides, proteins, and even whole 
viruses or cells (Proske, Blank et al. 2005; Yan, Bell et al. 2005; Bunka and Stockley 
2006; Lee, Stovall et al. 2006). Aptamers typically assume defined, compact secondary 
and tertiary structures and demonstrate high affinities (Kd values in the nanomolar range) 
and selectivities for their targets. 
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Aptamers often undergo conformation changes upon binding to their targets, and 
these conformational changes can be further magnified by engineering. Structure-
switching aptamers are typically created by manipulating the secondary structure of an 
aptamer, so that two conformations can be assumed, one in the absence of the cognate 
analyte and a different one in the presence of the analyte. For example, Tan’s group 
modified an PDGF aptamer beacon so that it was unfolded in the absence of PDGF but 
assumed its secondary and tertiary structure in its presence (Fang, Sen et al. 2003; 
Vicens, Sen et al. 2005). Labels appended to the aptamer led to fluorescence quenching 
in the presence of PDGF. This “folding” strategy can be generalized to the detection of 
small molecule analytes, such as cocaine (Stojanovic, de Prada et al. 2001). A variation 
on this theme is to add sequences in cis or in trans to an aptamer to stabilize an 
alternative secondary structure and then have the aptamer refold in the presence of 
analyte, again with a change in fluorescent signal (Yamamoto, Baba et al. 2000; 
Hamaguchi, Ellington et al. 2001; Bayer and Smolke 2005). The use of antisense DNA 
oligonculeotides in trans has proven to be a particularly facile strategy for generating so 
called aptamer beacons (Nutiu and Li 2003; Nutiu and Li 2004; Nutiu, Yu et al. 2004). 
Indeed, this “refolding” strategy has proven adaptable to detection via either 
electrochemical couples (Xiao, Piorek et al. 2005) or nanoparticle signaling strategies 
(Levy, Cater et al. 2005; Liu and Lu 2005). Quarternary structural changes (adjacent 
binding of two different aptamers) have also been exploited for signaling (Heyduk and 
Heyduk 2005). 
We believe that analyte-mediated conformational changes in aptamers can also be 
transduced to powerful nucleic acid amplification and detection methods. Analyte-
mediated protection of an aptamer from exonuclease digestion preceded oligonucleotide 
ligation and PCR and could be used for the detection of a few hundred thrombin 
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molecules (Wang, Li et al. 2005). Proximity methods in which two aptamers bind 
adjacent to one another and are ligated have been harnessed to both RCA and PCR 
amplification technologies (Fredriksson, Gullberg et al. 2002; Di Giusto, Wlassoff et al. 
2005), and zeptomole amounts of PDGF were detected (Fredriksson, Gullberg et al. 
2002). It is noteworthy, though, that these methods were not for the most part adapted to 
real-time detection.  
One of the simplest and most robust methods for generating conformation-
switching aptamers is to utilize an antisense sequence either in cis or trans to disrupt 
aptamer structure and function (Hamaguchi, Ellington et al. 2001; Nutiu and Li 2003; 
Bayer and Smolke 2005). Based on our design of the structure-switching aptamer in 
chapter 4, we have now engineered a structure-switching aptamer that upon interaction 
with its analyte (PDGF) can be circularized and the product detected by real-time RCA. 
This method can potentially be adapted to multiple aptamers, and the real-time nature of 
the amplification reduces background and improves detection significantly. 
RESULTS AND DISCUSSION
Designs for analyte-dependent aptamer circularization 
Previously, we have shown that analyte-dependent aptazyme catalyzed ligation of 
can be used in conjunction with rolling circle amplification for the sensitive detection and 
quantitation of small molecules such as ATP (Cho, Yang et al. 2005). However, this 
method was inherently limited by the fact that to date very few aptazyme ligases have 
been designed or selected.  In contrast, large numbers of aptamers have been selected 
(see, for example, the Aptamer Database http://aptamer.icmb.utexas.edu). In order to 
adapt aptamer recognition of analytes to real-time amplification methods such as RCA 
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we used protein enzyme catalyzed ligation (rather than a ribozyme-mediated ligation) and 
designed conformation-switching aptamer beacons that could be circularized (Figure 3-
1).
This design was based on the three-piece system we developed in Chapter 4, 
where the antisense sequences were in trans with the aptamers. To create a padlock 
probe, both the antisense sequence and the substrate sequence were attached to either end 
of the anti-PDGF aptamer (Figure 3-1). In the presence of PDGF, the 13 nucleotide 
antisense sequence would form ligation junction with the 5’ end of the aptamer, resulting 
in aptamer circularidization by T4 DNA ligase. With additional RCA reagents, the 
amplification of PDGF-dependent ligation could be monitored in real time. 
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In the binding conformer, the 3’ sequence extension should be displaced from the 
aptamer and form a short hairpin structure (Figure 1, blue). The 6 nt substrate sequence  
in the previous three-piece ligation was added to the aptamer via another linker (Figure 
Figure 3-1. Design for PDGF-activated circularization. (A) General design principles. 
The lengths of different DNA segments in the aptamer are not drawn to scale in the 
three steps illustrated. The original aptamer is shown in red. Blue sequence is added to 
the 3’-end of the aptamer in order to promote the formation of a duplex structure and 
denature the aptamer. Green sequence is added to the 5’-end of the aptamer; there is 
also a 5’-phosphate. In the presence of a protein analyte such as PDGF, the 3’-
extension (blue) is displaced and hybridizes with the 5’-end to form a ligation 
junction. This conformational change is assisted by the formation of a short hairpin 
structure involving the 3’-extension. Following ligation with T4 DNA ligase, the 
circularized aptamer can serve as a template for RCA. (B) Sequence and secondary 
structure of the designed anti-PDGF, conformation-switching aptamer N5C0. The 5’- 













1B, green) and could potentially pair with this hairpin structure to form a ligation 
junction (Figure 1B) for the aptamer termini that could be closed with T4 DNA ligase.  
Ligation of the adjacent ends leads to the circularization of the aptamer.   
The two linker regions were very important for feasibility of ligation because the 
participation of two proteins (the analyte and the DNA ligase) in the ligation reaction 
meant that the analyte-binding domain of the aptamer had to be well-separated from the 
ligation junction. In addition, the linker should not interfere with either substrate or 
antisense sequence binding. As the designed three-piece analyte dependent ligations, the 
protein-dependent circularization of the engineered anti-PDGF aptamer is 
mechanistically similar to other signal transduction strategies that have been developed 
for aptamers (Rajendran and Ellington 2002; Cho, Rajendran et al. 2005; Yang and 
Ellington 2006). Such as displacement of an antisense oligonucleotide upon re-folding, as 
pioneered by Li’s group (Nutiu and Li 2003; Nutiu and Li 2004) and the antiswitch 
strategy adopted by Bayer and Smolke (Bayer and Smolke 2005). For example, our 
strategy is similar to some aptamer beacon strategies that have previously been 
developed. In general, aptamer beacons can be categorized as either undergoing ligand-
dependent folding from an unfolded state or ligand-dependent refolding from a folded 
state. Presumably, both apatmer and antisense sequences together on a single strand there 
should be less conformational heterogeneity in the starting population, and this may in 
turn reduce background. Our designs are different from the antiswitch strategies by 
building a hairpin stem into the displaced sequences. Since this hairpin is essential for the 
formation of a ligation junction, the sequence and the length of the hairpin stem can also 
potentially be rationally manipulated in order to further poise the aptamer between 
binding and non-binding conformations. Also base numbers and sequences at the other 
side of the ligation junction would be optimized to improve the detection.    
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Observation of analyte-mediated aptamer circularization 
To confirm that circularization occurs, ligation products were separated on a 
denaturing gel. There was significantly more circular product in the presence of PDGF-
BB than in its absence (Figure 3-2, lanes 2 and 4). In addition, the aptamer was treated 
with or without PDGF and T4 DNA ligase followed by exonuclease VII digestion.  
Unligated, single-stranded, aptamers should be digested, while the rearranged, 
circularized conformers should not be digested (Figure 3-2, lanes 3 and 4). As expected, 
the circular, ligated aptamer is seen in the presence of PDGF and remains following 
exonuclease digestion. Finally, digested ligation mixture was amplified by RCA. There 
was significantly more amplified product in the presence of PDGF than in its absence 
(Figure 3-2, lane 5 and 6). 
Figure 3-2. Circularization and amplification of N5C0. Ligation reactions were 
carried out in the presence (Lanes 2, 4, 6) and absence of PDGF (Lanes 1, 3, 5) at 
room temperature for 16 h, and treated with exonuclease VII (Lanes 3, 4) for 1h.  
Exonuclease VII digested samples were amplified by RCA at 37 
o
C for 1 h. Samples 
were separated on a denaturing 8 % polyarylamide gel and stained with SYBR Gold.  
M represents 10 bp DNA ladder. Arrows show the linear and circularized aptamers. 
Linear
Circle




Figure 3-3. Design for a new construct N5C1 by optimization of the two linkers of the 
N5C0. (A) General design principles for real-time SYBR Green detection based on 
Figure 3-1. In RCA, probes form duplexes with the amplification product. SYBR 
Green binds to the double stranded regions and generates fluorescence. (B) Sequence 
and secondary structure of the designed anti-PDGF, conformation-switching aptamer 
N5C1. Additional linker regions between the aptamer and the 5’ and 3’ extensions 














Introducing a probe sequence for real-time amplification 
Initially, we designed construct N5C0 and carried out real-time RCA detected by 
SYBR Green. However, the real-time RCA signals were very weak and hard to quantitate 
(data not shown). This was probably due to few double stranded regions formed by the 
amplified product at 37 
o
C. Therefore, we introduced probe oligonucleotides to bind to 
the RCA product to form duplex for SYBR Green sensing.  
This design takes the advantage of the linker regions. We designed a new 
construct N5C1, whose linker regions are suitable for primer and probe binding for real-
time RCA. The design of the linker regions was based on the following concerns: these 
regions should not have any secondary structure while contain certain number of GC 
bases for stable primer and probe binding. The secondary structure was conformed by 
Mfold (http://www.bioinfo.rpi.edu/applications/mfold/old/dna) and the Tm values of the 
linker regions were kept above 40 
o
C, which should above the amplification temperature 
(37
o
C). These designs were also assessed computationally. The energies of the 
conformational equilibrium between the non-binding, duplex DNA conformer and the 
three way junction binding-competent conformer were roughly predicted by specifying 
those structures in. The free energy of folding of the non-binding conformation was 
predicted to be -19.2 kcal/mol, while the free energy of folding of the binding 
conformation was predicted to be -14.1 kcal/mol. The free energy of protein binding was 
estimated to be -13.7 kcal/mol based on the reported Kd value (Green, Jellinek et al. 
1996). Therefore, given the typical caveats that apply to secondary structure prediction in 
nucleic acids (failure to assess pseudoknots and tertiary structural interactions; 
assessment of individual structures rather than structural ensembles) the energy of 
protein-binding should be more than sufficient to substantially alter the conformational 
equilibrium. 
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To confirm that circularization occurs, ligation products were separated on a 
denaturing gel. There was significantly more circular product in the presence of PDGF-
BB than in its absence (Figure 3-4, lanes 1 and 2). In addition, the aptamer was treated in 
either the absence or presence of PDGF and T4 DNA ligase followed by exonuclease VII 
digestion. Unligated, single-stranded, aptamers should be digested, while the rearranged, 
circularized conformers should not be digested (Figure 3-4, lanes 3 and 4). In fact, a 
circular, ligated aptamer is seen in the presence of PDGF and remains following 
exonuclease digestion. 
Figure 3-4. Circularization of the conformation-switching aptamer N5C1. Ligation 
reactions were carried out in the presence (Lanes 1, 3) and absence of PDGF (Lanes 2, 
4), and treated with exonuclease VII (Lanes 3, 4). Samples were separated on a 
denaturing 8 % polyacrylamide gel and stained with SYBR Gold. M represents 10 bp 
DNA ladder.  Arrows show the linear and circularized aptamers. 




Real-time amplification of analyte-mediated aptamer circularization 
In order to determine whether the observed, analyte-mediated circularization 
could be detected by RCA, we again used gel assays to examine the amplification 
product.  Following ligation, RCA was carried out within one hour. The amplification 
products were very high molecular weight DNA that could not enter a denaturing 
polyacrylamide gel (data not shown).  
To initiate RCA, aliquots of terminated ligation reactions were mixed with RCA 
primers that bound within an unstructured portion of the 5’ extension (Figure 3-3). In 
order to amplify and quantitate circularized products in real time, a probe oligonucleotide 
that was identical to an unstructured portion of the 3’ extension (Figure 3-3) was also 
included in the reaction. The probe could bind to the RCA product and the double-
stranded DNA could in turn be detected with SYBR Green. In order to improve assay 
reproducibility the T4 gene 32 protein was included. This single-stranded DNA binding 
protein has previously been used in a variety of RCA assays to help melt double-stranded 
structures that can block polymerization (Lizardi, Huang et al. 1998; Qi, Bakht et al. 
2001).
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Figure 3-6. Detection as a function of ligation time. Ligation reactions were carried 
out in the presence (black bars) or absence (grey bars) of 40 nM PDGF-BB and then 
detected via real-time RCA. Signals were determined either based on (A) fluorescence 
endpoint values after 90 min, or (B) amplification rates (obtained from the linear 
regressions of data collected from 20-90 min, see Figure 3-5). 
Ligation time (min)















































Figure 3-5. Real-time RCA detection of PDGF. Arbitrary fluorescence units were 
collected based on SYBR Green intercalation into concatamer-probe duplexes and 































Ligation reactions containing 40 nM PDGF-BB were initially carried out within 
60 min, and real-time RCA was then monitored over 90 min (Figure 3-6). The addition of 
probe was necessary to see robust fluorescent signals (data not shown). In order to keep 
protein concentrations uniform and to avoid loss of analyte, PDGF-BB was diluted into 
BSA that was at a final concentration of 0.004 % in this and all other experiments.  
Initial results with 40 nM PDGF-BB revealed protein-dependent signals at all of the 
ligation timepoints assayed (Figure 3-6). However, a maximal signal-to-background ratio 
was achieved after ligation reactions had proceeded for one hour. It is noteworthy that 
background signal did not seem to accumulate over time. Indeed, the fact that 
reproducible signals could be observed at ligation timepoints as short as 5 minutes bodes 
well for the further development of high-throughput diagnostic assays. Nonetheless, for 
the purposes of methods development all additional experiments were carried out using a 
one hour ligation time.  
Using these standard assay procedures, RCA signals were monitored as a function 
of time at a variety of protein concentrations (Figure 3-5). PDGF-BB concentration as 
low as 1.6 nM could be readily detected. The RCA reaction was roughly linear over time 
and because of this it proved possible to generate standard curves for detection (Figure 3-
7). Irrespective of whether the end point (90 min) of the RCA (Figure 3-7A) or the rate of 
accumulation of product (Figure 3-7B; obtained from the linear regressions of data 
collected from 20-90 min, see Figure 3-5) was used, the assay demonstrated good 
responsivity between low concentration of PDGF-BB and 80 nM PDGF-BB. The black 
line in these dose-dependent curves represents the best fit using 3-parameter Hill 
equations (SigmaPlot, SPSS).   
The detection limits (1.6 nM) observed in our assay were similar to those 
observed with other detection methods involving the anti-PDGF aptamer, including an 
 62
aptamer beacon developed by Tan’s group (Fang, Sen et al. 2003; Vicens, Sen et al. 
2005), fluorescence anisotropy (Fang, Cao et al. 2001), a colorimetric determination 
technique using aptamer-modified gold nanoparticles (Huang, Huang et al. 2005), a 
luminescence detection strategy (Jiang, Fang et al. 2004), and an exciton detection 
strategy (Yang, Jockusch et al. 2005). The similarity between the detection limits is not 
surprising, since in each instance detection is ultimately limited by the binding affinity 
(Green, Jellinek et al. 1996) of the aptamer itself. As even higher affinity aptamers are 
developed, it seems possible that the amplification methods that we have developed here 
may yield even lower detection limits, as our conformation-switching aptamers are not 
labeled and hence there is no initial background fluorescence. 
Figure 3-7. Dose-response curves for real-time RCA. Signal was determined as a 
function of protein concentration based on either (A) fluorescence endpoint values 
after 90 min, or (B) amplification rates. The black lines represent the best fit to the 
Hill equation: bbb xcaxyy /0  using SigmaPlot (SPSS, Chicago, IL). 
PDGF (nM)












































Indeed, our results were extremely encouraging for the generality of the method, 
since it can be expected that at least some of the binding energy of the original aptamer 
was transduced into conformational change in the engineered aptamer, and thus the Kd
value of the engineered aptamer was likely higher than 0.1 nM. Previous attempts to 
engineer conformational changes in aptamers have shown reductions in binding affinity. 
For example, conformation-switching aptamer beacons for thrombin and ATP showed 
apparent decreases in affinities for thrombin and ATP of 2- and 60-fold, respectively 
(Nutiu and Li 2003). It is precisely because binding energy is of necessity transduced into 
conformational change and potentially reduced sensitivity that we believe it is important 
to couple conformation-switching aptamers to signal amplification methods.  
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Figure 3-8. Altering signal by altering aptamer sequence. (A) Design of NC52. Based 
on N5C1 (Figure 3-3B) we made N5C2, which has one more basepair at the 5’ end of 
the ligation junction (boxed). (B) RCA assay of NC52. Signal was determined as in 




















































While it is significant that our designed construct could detect nanomolar levels of 
protein in a simple RCA assay format, additional changes in the sequence of the 
engineered aptamer may lead to improved responsivities and sensitivities. While we 
attempted to ensure that the primer and probe binding sites were largely unstructured, 
further destabilization of any nascent intramolecular secondary structures should further 
encourage the initiation of RCA and the accumulation of signal. More importantly, 
manipulating the number and type of basepairs in the unbound, inactive and/or bound, 
active conformers should differentially influence the free energies of folding for these 
states, and hence should influence the relative levels of background and protein-
dependent circularization and signal that are observed. As an initial test of this 
hypothesis, we added a single basepair to the active conformer (aptamer N5C2; Figure 3-
8A). While the overall design still worked and yielded a PDGF-dependent real-time RCA 
signal, the background observed was higher, and the overall level of activation for N5C2 
Figure 3-9. Specificity of response. Reactions were carried out and analyzed as in 
Figure 3-6, except that either 40 nM PDGF-AA, -AB, or -BB were used. In addition, 
negative controls were carried out in the absence of protein or in the presence of BSA 
(0.004 %). 











































was roughly half that determined in parallel with N5C1 (4.3 (endpoint) and 5 (rate) for 
N5C2, versus 9.3 (endpoint) and 12 (rate) for N5C1) (Figure 3-8B). These results suggest 
that it should be possible to further optimize the performance of engineered aptamers for 
analyte-mediated circularization and RCA, and we are currently attempting to determine 
how designed sequences, computational structure predictions, and signaling function 
correlate with one another. These efforts will be enhanced by the fact that the antisense 
sequences in our design can fold into a hairpin stem. By manipulating the sequence and 
length of this hairpin, we should be able to better poise the conformation-switching 
aptamer between binding and non-binding conformations. Selection experiments can also 
be carried out to identify optimum sequences for folding transitions and RCA, and may 
further increase the sensitivity of the assay. 
The specificity of the designed aptamer biosensor was assayed using different 
dimeric isoforms of PDGF: PDGF-AB and AA (Figure 3-9). Signals were seen with both 
PDGF-BB and PDGF-AB, but not with PDGF-AA, as was expected given that the 
aptamer was originally selected to bind to the B-chain. The signal with PDGF-BB was 
greater than the signal with PDGF-AB, as has previously been observed by others (Fang, 
Cao et al. 2001; Fang, Sen et al. 2003; Yang, Jockusch et al. 2005; Zhou, Jiang et al. 
2006). Interestingly, the addition of either PDGF-AA or BSA slightly suppressed the 
background signal observed in the absence of protein, possibly by competing with DNA 
ligase for non-specific binding to the aptamer.  
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Figure 3-10. PDGF detection against a background of cell lysate. Signal was 
determined as in Figure 3-7, except that ligation reactions were carried out in 10 
µg/mL human 293T fibroblast cell lysate. Signal was determined as a function of 
protein concentration based on either (A) fluorescence endpoint values after 90 min, or 
(B) amplification rates. The black lines represent the best fit to the Sigmoid equation: 
)//( 01/
bzbx
eay  using SigmaPlot. 
Figure 3-11. Specificity of response in a background of cell lysate. Reactions were 
carried out and analyzed as in Figures 3-6 and 3-9. Negative controls included lysate 
with no additions (‘lysate’) or lysate + 0.004 % BSA (‘BSA’). 
PDGF BB (nM)





















































































Real-time RCA detection of PDGF against a background of cell lysate 
Real-time RCA experiments were repeated in a manner similar to that described 
above, except that PDGF at different concentrations was doped into human 293T 
fibroblast cell lysate (final total protein concentration of 10 µg/mL). As before, the total 
sample reaction time prior to amplification was only 1.5 hours, and real-time 
amplification was monitored over 90 minutes. As shown in Figure 3-10, even though the 
reaction mix now contained multiple proteins and nucleic acids the structure-switching 
aptamer coupled with real-time RCA once again yielded dose-response curves for PDGF-
BB that were qualitatively similar to those previously observed (Figure 3-7). The rate of 
amplification was lower than in the absence of lysate, which may be explained by the 
presence of interfering degradative enzymes, enzyme inhibitors, or contaminating nucleic 
acids. Further optimization of the reaction for clinical samples should further improve 
responsivity. Nonetheless, very little response was observed in the absence of introduced 
PDGF, consistent with the lack of this cytokine inside of cells (as opposed to in serum), 
and PDGF concentrations as low as 1.6 nM could still be detected though the lysate 
proteins were in 1,000-fold (w/w) excess. These results were especially remarkable given 
that the mixture spent 90 minutes prior to real-time RCA in the presence of active 
nucleases. Once again, the assay showed very high specificity for the PDGF-BB and -AB 
dimers as opposed to PDGF-AA or other unrelated proteins (Figure 3-11). PDGF levels 
in human serum have been found to be 14.4-24.8 ng/mL, which is equivalent to 
subnanomolar concentrations (Singh, Chaikin et al. 1982; Bowen-Pope, Malpass et al. 
1984). The sensitivities observed with our method are very similar to these physiological 
levels. In addition, PDGF levels have been reported to be elevated in many diseased 
tissues (Green, Jellinek et al. 1996). Therefore, with further optimization our detection 
method may prove to be feasible for PDGF detection in clinical samples. 
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Chip-based RCA assay 
We have previously used aptazymes and chip-based RCA to detect ATP in 
Chapter 2 (Cho, Yang et al. 2005). It should also be possible to use conformation-
switching aptamers in a similar manner. The RCA primer was conjugated to biotin either 
via a C3 spacer phosphoramidite or a dT residue at its 5’ end (Figure 3-12). The modified 
primers were immobilized on streptavidin-coated glass slides. A mixture of analyte-
mediated ligated circles and components of a RCA reaction (polymerase, dNTPs) was 
incubated with the primer array for 30 min at 37
o
 C. The concatamer products were then 
hybridized with a Cy3-labeled probe. 
Figure 3-12.  PDGF-mediated RCA on a chip array. A primer labeled with biotin at 
its 5’ end was immobilized on a streptavidin-coated glass slide. Terminated ligation 
reactions containing circularized aptamers (red) and RCA reagents were applied to the 
chip, and RCA was initiated from the 3’ end of the immobilized primer. Elongated 







Figure 3-13.  Detection of PDGF via RCA on a chip array. (A) Fluorescence images 
acquired with an Axon Instruments 4000B confocal microarray scanner in the 
presence of 0, 8, 20, and 80 nM PDGF-BB. (B) Amplified signal at a series of PDGF 
concentrations using primers with either a biotin-C3-linker or primers with a biotin-
dT-linker. 
0nM                 8nM             20nM               80nM
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The detection of PDGF-BB in three replicate experiments is shown in Figure 11.  
While there is some background that prevents detection at the lowest concentration 
assayed (4 nM), analyte-dependent amplification can be readily observed on the chip at 8 
nM (Figure 3-13A), and signal saturates at higher (> 20 nM) PDGF concentrations 
(Figure 3-13B). There was no significant difference between results obtained with the 
two types of linkers. Signal saturation may have been due to either the completed 
production of DNA concatamers or to fluorescence self-quenching of the saturated spots.  
The combination of high background and signal saturation in the end point assay limited 
sensitivity relative to the real-time assay (compare with Figure 3-5), and further 
emphasizes the current superiority of real-time assays for protein detection. 
Nonetheless, it should eventually be possible to use structure-switching aptamers 
or aptazymes and chip-based RCA assays for quantitation. Chip-based RCA assays have 
previously been used to quantitate both DNA and protein molecules (Nallur, Luo et al. 
2001; Schweitzer, Roberts et al. 2002). An immunoRCA assay reported by Schweitzer et
al. yielded a dose-response curve over a greater range of IgE concentrations than a 
corresponding ELISA assay; the sensitivity of detection was two orders of magnitude 
greater (Schweitzer, Wiltshire et al. 2000). ImmunoRCA can also be used to profile the 
expression of many different proteins from cell lysates in a high-throughput manner, 
although purified proteins had to be used as quantitation standards (Schweitzer, Roberts 
et al. 2002). However, in general there are relatively few examples of quantitative, chip-
based RCA (Nallur, Luo et al. 2001; Schweitzer, Roberts et al. 2002) and chip-based 
RCA does not have sensitivites as good as those of ELISA assays (Kingsmore and Patel 
2003). The reasons are likely similar to those we have cited above, that in chip-based 
methods background accumulation of RCA products can be quite high. 
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Overall, in order to fully develop quantitative RCA methods it may be much 
better to use real-time rather than chip-based methods. However, it is generally difficult 
to develop immunoRCA methods that can be analyzed in real time, largely because 
unbound antibodies must be removed prior to amplification. Conformation-switching 
aptamers and aptazymes that can form circular templates upon addition of protein 
analytes are one of the few methods that may be compatible with performing real-time 
protein detection with RCA. Similarly, Di Giusto et al. have developed a proximity 
method in which a circular template and a primer are brought together by a protein 
intermediary (thrombin) (Di Giusto, Wlassoff et al. 2005). However, this method requires 
the identification of affinity reagents that bind to two different epitopes on a protein 
surface, similar to a sandwich assay. While the real-time RCA assay reported here is 
somewhat less sensitive (0.4 nM versus 0.03 nM), the conformation switching aptamers 
recognize only a single epitope. Moreover, binding, ligation, and amplification can 
potentially all occur in the same reaction mixture, and one-step real-time RCA reactions 
may be possible. 
CONCLUSIONS
While conformation-switching aptamers have previously been used as biosensors, 
the methods that have previously been pursued were not in general of use for adapting 
aptamers to real-time nucleic acid amplification methods. Therefore, we designed a 
conformation-switching aptamer that could assume a circular conformation in the 
presence of a protein analyte, PDGF, and subsequently ligated with T4 DNA ligase. This 
allowed the specific detection of PDGF by real-time RCA, at concentrations down to 1 
nM or better. Detection did not suffer from the addition of other proteins or even cell 
lysate. While the conformation-switching aptamer could also be adapted to surfaces, it 
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proved difficult to quantitate RCA on a chip, further emphasizing the importance of real-
time amplification methods for sensitive analyte quantitation. While nucleic acid and 
other affinity reagents have previously been adapted to real-time methods using 
proximity methods (i.e., the proximity ligation assay, PLA) these methods all require two 
different aptamers or other affinity reagents. In contrast, almost any single aptamer can be 
adapted to the conformation-switching, circularizing format described, and this 
demonstration should therefore facilitate a more general use of real-time nucleic acid 
amplification methods for the detection of proteins. 
FUTURE PLANS
Future plans of analyte-dependent aptamer circularization followed by real-time 
RCA could focus on both improvement of current detections and applications for other 
analyte detections. 
Though our method could sensitively detect PDGF both in solution and cell 
lysate, the detection could be further improved by both rational design and in vitro
selections. The linker regions connecting ligation junction and the aptamer, lengths and 
sequences in the ligation junction, and number and bases in the antisense sequences could 
all be optimized. Using computational design, folding energies of the inactive, non-
binding conformer and the active, binding conformer could be calculated. Therefore, the 
analyte-dependent ligation activities of designed constructs could be predicted. However, 
rational design may not be able to perfectly predict the behavior of any sequences and 
structures. Therefore, in combination of in vitro selection, the generation of better 
constructs could be more possible. 
On the other hand, our method should be generalizable to other analyte detections. 
DNA aptamers for both small molecule and protein detections could be adapted to our 
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methods. For example, aptamers for the detections of thrombin (Bock, Griffin et al. 
1992), IgE (Wiegand, Williams et al. 1996) and ricin (Tang, Xie et al. 2006) could be 
adapted. However, for protein detections, the lengths of the linker regions separating 
aptamer binding and ligation junction need to optimize and aptamers of such lengths may 
not be synthesized. Therefore, ligating two ssDNAs may be a good way to generate the 
full length the padlock aptamer. In contrast, for the adaption of small molecule binding 
aptamer such as the anti-cocaine aptamer (Stojanovic, de Prada et al. 2001), the length of 
the aptamer may not be a big issue.  
In all, both optimization and generalizability of this strategy are worthy being 
explored in the future. 
MATERIALS AND METHODS
Materials  
The following oligonucleotides were purchased from IDT (Coralville, IA). The 
circularizing aptamers N5C0, N5C1 and N5C2 (sequences shown in Figure 3-1, 3-3 and 
3-8) had phosphates at their 5’-ends. The primer, biotin-dT-primer, and biotin-C3-primer 
for RCA all shared the same sequence (5’-AGTTGGAGAGAGTGGGAG). The sequence 
of both real-time and 5’-Cy3-labeled RCA probes was 5’-GGTGTGTTGTTGATG. 
PDGF-BB, -AA, and -AB were purchased from R&D Systems (Minneapolis, MN). The 
PDGF proteins were reconstituted in 4 mM HCL with 0.2 % BSA (Invitrogen, Carlsbad, 
CA), as suggested by the supplier. 
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Ligation assays 
Preligation mixtures (46.5 µL) contained 40 nM N5C1, 137 mM NaCl, 10.1 mM 
Na2HPO4, 1.8 mM KH2PO4, pH 7.4, 2.7 mM KCl, 10 mM Tris-Cl, pH 7.4, and 2.5 mM 
MgCl2. The reaction mixture was incubated with PDGF-BB for 30 min, and then 1.5 µL 
of 25 mM ATP and 1 µL of T4 DNA ligase (2 units/ µL, Epicentre, Madison, WI) were 
added separately. Ligation proceeded for various times at room temperature (see Figure 
2-6) and were terminated by heating at 95 C for 15 min. Ligated and unligated species 
were separated on denaturing (7 M urea) 8 % polyacrylamide gels and stained with 
SYBR Gold (Molecular Probes, Eugene, OR). 
To carry out assays in lysate, 1x10
7
 human 293T fibroblast cells (ATCC, 
Manassas, VA) were collected. Cells were treated with 4 mL of M-PER mammalian 
protein extraction reagent (Pierce Biotechnology, Rockford, IL) and shaken at room 
temperature for 10 min. After centrifugation at 10,000 rpm at 4 C for 25 min, pellets 
containing cell membranes and hydrophobic membrane proteins were removed, and the 
supernatant consisting of intracellular proteins and nucleic acids was collected and frozen 
at -80 C. Total protein in lysate aliquots was quantitated using a bicinchoninic acid total 
protein assay kit (Pierce Biotechnology). The final concentration of lysate proteins in 
each 50-µL ligation reaction mixture was 10 µg/mL, and PDGF at different 
concentrations was added the lysates. PDGF samples were always in 0.004 % BSA; 
irrespective of PDGF concentration, BSA was always in excess. Ligation reactions were 
then carried out as described above. 
Real-time RCA measurements 
The primer and probe for RCA were denatured at 95 C and then cooled to room 
temperature. The primer (final concentration 0.3 µM) and probe (final concentration 1.3 
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µM) were added to the RCA reaction mixture containing 1x phi29 reaction buffer (40 
mM Tris-HCl pH 7.5, 50 mM KCl, 10 mM MgCl2, 5 mM (NH4)2SO4, and 4 mM DTT), 
416 µM dNTPs (Epicentre), 1.5 µL of SYBR Green I (1: 2000 dilution of a 10,000x
solution as described by the manufacturer; Cambrex, Rockland, MI), 3 units of phi 29 
DNA polymerase (Epicentre) and 66.7 ng/µL T4 gene-32 protein (Ambion, Austin, TX), 
all in a 30- µL total volume. Finally, 4 µL of each terminated ligation mixture was added 
right before starting the real-time RCA reaction. Real-time RCA was carried out in a 96-
well PCR plate (Applied Biosystems (ABI), Foster City, CA) covered with optical strip 
caps (ABI) at 37 C for 90 min. Fluorescence accumulation was monitored in the green 
channel in an HT7900 real-time PCR instrument (ABI).  
RCA on a chip  
Primers were immobilized on glass slides for RCA assays. A solution of 500 nM 
biotin-C3-primer or biotindT-primer in Tris buffer (50 mM Tris-HCl, pH 7.4) containing 
5 % glycerol was heat denatured at 70 
o
C for 3 min and then cooled to room temperature 
before printing. The primers were printed onto streptavidin-coated glass slides (Pierce 
Biotechnology) using a manual arrayer (V&P Scientific, Inc., San Diego, CA) as 
previously published in Cho et al. (Cho, Yang, et al., 2004). The slides were incubated 
within a humidity chamber for 1 h after printing to allow conjugation of biotinylated 
oligonucleotides to streptavidin. The printed area was enclosed within a CoverWell 
incubation chamber (Schleicher and Schuell, Keene, NH), and 1 mL of Tris buffer 
containing 0.05 % (v/v) Tween 20 was pipetted into each chamber through access ports. 
Each chamber was then incubated with 70 µL of RCA mixture (40 mM Tris-HCl pH 7.5, 
50 mM KCl, 10 mM MgCl2, 5 mM (NH4)2SO4, 4 mM DTT, and 10 µL of terminated 
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ligation mixture) at 37 C for 30 min. The RCA reaction was terminated by washing the 
chamber with 1 mL of 2x SSC (300 mM sodium chloride and 30 mM sodium citrate, pH 
7.4) buffer containing 0.05 % Tween 20. Cy3-labeled probe in 2x SSC with 0.05 % 
Tween 20 was hybridized to RCA products at 37 C for 30 min. Slides were washed 
twice with 2x SSC with 0.05 % Tween 20 solution, twice with 1x SSC with 0.05 % 
Tween 20 solution, and once with 0.5x SSC. Slides were dried by immediate 
centrifugation and scanned on an Axon Instruments (Union City, CA) 4000B confocal 
microarray scanner. Images were analyzed using GenePix 4.1 software (Axon 
Instruments). 
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Chapter 4: Detection of protein analyte using aptamer mediated three- 
and four-piece ligation systems followed by real-time PCR 
INTRODUCTION
ImmunoPCR methods can be used for the sensitive detection of protein analytes 
(Adler 2005; Niemeyer, Adler et al. 2005; Barletta 2006), but have several distinct 
disadvantages relative to PCR for the detection of nucleic acids. It is difficult to 
reproducibly prepare antibody-DNA conjugates, binding and amplification reactions 
must be separated in time, preventing the development of real-time formats; and both 
specifically and non-specifically bound probes can be amplified, potentially leading to 
high background signals.   
In order to better couple protein detection with nucleic acid amplification, nucleic 
acid binding species (aptamers) have been adapted to a variety of amplification assays, 
including exonuclease-protection mediated ligation followed by PCR (Wang, Li et al. 
2005); and proximity extension by rolling circle amplification (RCA) (Di Giusto, 
Wlassoff et al. 2005; Soderberg, Gullberg et al. 2006). Aptamers have also been used for 
the generation of allosteric ribozymes (aptazymes) that have similarly been coupled to 
amplification reactions (Robertson and Ellington 2001; Cho, Yang et al. 2005). 
Proximity ligation assay (PLA) is the focus of current PCR based detection. In 
this case, oligonucleotide probes are attached to the binders (either aptamer or antibody) 
(Fredriksson, Gullberg et al. 2002; Gullberg, Gustafsdottir et al. 2004; Gustafsdottir, 
Schallmeiner et al. 2005; Gustafsdottir, Nordengrahn et al. 2006; Schallmeiner, Oksanen 
et al. 2007). The probes are brought adjacently by at least two epitopes binding to the 
antibodies or aptamers on the analyte. Fredriksson et al. (2002) could detect zeptomole 
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PDGF through proximity DNA ligation followed by PCR. PLA has also been carried out 
for oligonucleotide circularization followed by RCA (Soderberg, Gullberg et al. 2006).  
However, proximity based ligation requires multi-meric analyte or at least two 
binders recognizing different epitops on the analyte. Such disadvantage limits the 
generazliability of this assay. Therefore, a generalizable method capable of sensitive and 
specific detection needs to be developed. 
We and others have previously reported that aptamers can be engineered so as to 
transduce the binding energy of ligands into changes in aptamer conformations. The 
resultant analyte dependent folding of aptamers have been used to optically signal the 
presence of ligands in solution (Stojanovic, Prada et al. 2000; Yamamoto, Baba et al. 
2000; Hamaguchi, Ellington et al. 2001; Stojanovic, de Prada et al. 2001; Li, Fang et al. 
2002). For example, an anti-thrombin aptamer that formed a quadruplex structure was 
extended so that it folded into a non-binding, stem-loop structure. A fluoropore and a 
quencher were placed at the termini of the non-binding stem-loop. Upon the addition of 
thrombin, the original quadruplex structure was stabilized, splitting apart the fluorophore 
and quencher, and yielding a fluorescent signal (Hamaguchi, Ellington et al. 2001). 
Thrombin could be detected in the nanomolar range, and no fluorescent signal was 
generated in with other, non-cognate proteases.  
The key feature of structure-switching aptamer technology (Nutiu and Li 2003; 
Bayer and Smolke 2005) is that it is generalizable to any kind of aptamers without 
knowing the aptamers’ secondary or tertiary structures. The main strategy is to use 
antisense oligonucleotide either in trans or in cis to form a duplex with the aptamer and 
oligonucleotide displacement occurs when analyte binding. When the aptamer and 
antisense oligonucleotide are fluorescently labeled, oligonucleotide displacement results 
in separation of the fluorophore and quencher (Nutiu and Li 2003) (Figure 4-1). In 
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another case, the displaced antisense oligonucleotide controls target expression by 
hybridization with the 5’ UTR of the mRNA (Bayer and Smolke 2005). Similarly, 
structure-switching aptamers have also been adapted to electronic (Xiao, Piorek et al. 
2005) and nanoparticle sensors (Levy, Cater et al. 2005; Liu and Lu 2005).   
By far, no approach has been developed to adapt structure-switching aptamers to 
PCR amplification. Probably it is not obvious how to generate amplicons. A variety of 




















Figure 4-1. Mechanism of antisense-mediated, structure-switching aptamers. 
Tripartite (A, D) and bipartite (B, C) quenched systems are designed based on aptamer 
and antisense sequences. Upon ligand binding, the equilibrium between the aptamer 
and the complementary antisense strand is shifted, and the complex is disrupted, 
resulting in dequenching of either a terminal or internal incorporated fluorophore. 
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but the most likely would be either to have aptamer conformational changes lead to the 
production of a template for PCR or a primer for PCR. The production of a PCR template 
would likely lead to greater sensitivity of detection, since conformational transduction to 
produce even a single template should lead to amplification, while multiple primers 
would have to change conformation in order to support an amplification reaction.  
However, a PCR template that was only amplified in one conformation would also likely 
lead to an inherently high background signal, since conformational equilibration even in 
the absence of analyte would lead to at least some template being available at all times, 
especially during thermal cycling and in the presence of a DNA polymerase that could 
read through restrictive conformations. 
Therefore, we decided to reduce background by requiring a ligation step to 
produce competent templates for PCR amplification. As we mentioned above, structure-
switching aptamers usually involves oligonucleotide displacement. So the switch between 
double stranded and single stranded nucleic acid would allow the design of the ligation 
junction. In this way, the ligation reaction can be separately optimized to reduce 
background and no further ligation should occur during thermal cycling. Most 
importantly, the ligation reaction can be directly coupled with a real-time PCR without 
additional wash or other steps.  
Inspired by the antisense strategy developed by Nutiu and Li (Figure 4-1; Nutiu 
and Li, 2003), we now propose to adapt such strategy to generate analyte-dependent 
product for real-time PCR. In the presence of analyte, the antisense oligonucleotide is 
displaced by analyte binding and changes into a signal stranded DNA, which will be used 
to construct the ligation junction. In our previous experience, we found that the ligation 
junction and the protein analyte binding site should be well separated to prevent steric 
hindrance (data not shown). To separate ligation junction and aptamer binding site, 
 82
similar to those designed by Nutiu and Li, we decide to have aptamer and antisense 
oligoncucleotide on separate molecules. Moreover, additional substrate oligonucleotides 
need to be designed to complete the ligation junction. Because the structure-switching 
aptamers usually have reduced affinities with their cognate analytes (Nutiu and Li, 2003), 
it will be important to determine if amplification could improve the sensitivity. In 
addition, our method will explore the possibility of using simple antisense methods to 
generally couple aptamers to ligation and signal amplification. 
We have applied these methods to the anti-PDGF aptamers in part because of the 
detailed knowledge that is already available regarding its binding characteristics and 
structures, but also to more readily compare our results with other biosensor paradigms 
that have previously been advanced. We find that the three-piece ligation could 
sensitively and specifically detect PDGF, however long ligation time (8 hours) is 
required.
RESULTS AND DISCUSSION
Rational of the design 
Previously, it has been shown oligonucleotide displacement coupled with 
fluorescence assay can be used for ATP and thrombin detection (Nutiu and Li 2003). 
However, fluorescence-based assays are not sensitive enough and have limitations such 
as enhanced background caused by impurity of dye-labeling, fluorescence quenching by 
improper environment and low detection signal due to single fluorophore labeling. 
Therefore, sensitivity and efficiency of the assay may be increased by creating aptamer 
biosensors that utilize nucleic acid amplification techniques. In order to adapt aptamer 
recognition of analytes to real-time PCR, we have designed an anti-PDGF aptamer 
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(Green, Jellinek et al. 1996) for protein dependent ligation based on an antisense strategy 
(Nutiu and Li 2003). First, we designed short oligonucleotides to test the feasibility of the 
PDGF activated aptamer ligation. Then, we optimized these oligonucleotide sequences 
for the purpose of real-time PCR. Finally, we developed ligation and real-time PCR 
assays and explored the specificity and sensitivity of the detections. 
T4 DNA ligase is usually the choice for specific ligation because its template 
dependent characteristics. It seals the nicks in double-stranded nucleic acids but can not 
ligate single-stranded nucleic acids. Therefore, the ligation junction was constructed by 
two oligonucleotide substrates hybridizing to a splint. As shown in Figure 4-1, in the 
presence of analyte the displaced antisense oligonucleotide is in free status in solution. 









Add T4 DNA ligase; 
substrate oligos
ligation
Figure 4-2. Schematic drawing of the strategy of four-piece ligation for analyte 
(PDGF) detection. In the absence of analyte, aptamer (black) forms a duplex structure 
with the antisense strand (red). Analyte binding displaces the antisense strand, which 
can serve as a template for two substrate oligonucleotides (blue and green) to be 
ligated by T4 DNA ligase.  
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However, the antisense strand could serve as either a ligation substrate or a splint. At this 
time point, we also concerned about the lengths of the antisense oligonucleotides. 
Previously, for ATP and thrombin detections, the duplex regions formed by the aptamers 
and the antisense strands were about 10-12 bp in lengths (Nutiu and Li 2003). The reason 
for such lengths is because in the absence of analyte the duplex needs to be stable under 
the assay temperatures (22-37 
o
C). In conjunction with ligation we proposed that the Tm 
values of the ligation junctions should be lower than those of the aptamer-antisense 
duplexes. Therefore, the lengths of the antisense sequences designed here might be even 
longer than those Nutiu and Li designed. On the other hand, we wanted to keep the 
minimal length of the ligation junction; for example, 6 basepairs at each side. So if the 
displaced strand is one of the substrates in the ligation junction, it is still possible that 
such antisense strand can bind to both ligation substrate and the aptamer simuteously. As 
a result, the background ligation level is high. Therefore, it would be better if the 
antisense strand serves as a splint for two substrate oligonucleotides (Figure 4-2).      











Based on these above concerns, complementary sequences to the anti-PDGF 
aptamer were designed to disrupt the binding conformation of the aptamer (Table 4-1, 
underlined sequences). These sequences start from the same 5’ ends and have different 
lengths at their 3’ ends. Also same sequences were added to the 5’ ends of the antisense 
oligonucleotides to complete the templates for ligations (oligonucleotides: 11p-15p in 
Table 4-1). Two substrate oligonucleotides (5’ SUB and 3’ SUB) were also designed to 
form six basepairs at each side of the ligation junction, respectively (Figure 4-2). The Tm 
of the ligation duplex is 38.3
 o
C, which is lower than the Tm of the antisense duplex 
formed by 12p-15p with the aptamer (Tm= 40.1-48.7
 o
C). So in the absence of PDGF, the 
aptamer-antisense duplex should be more stable than the antisense-substrate duplex. 
Analyte binding promotes the formation of aptamer-analyte duplex and the release of the 
antisense strand to bind to substrates for ligation. However, if the antisense is one base 
shorter (underlined sequence of 11p) its Tm (37.0 
o
C) is lower than that of the splint. 
Therefore, 12p, 13p, 14p and 15p were chosen for further ligation assays (Figure 4-3).  
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The proposed four-piece ligation system contains the anti-PDGF aptamer, 
antisense strand (12p-15p) and two substrate oligonucleotides (3’SUB and 5’SUB) 
(Figure 4-2). Before ligation, aptamers and the antisense strands were denatured together, 
followed by incubation with or without PDGF. Then substrate oligonucleotides, ATP and 
T4 DNA ligase were introduced in the pre-ligation mixture. In addition, ligation mixture 
without aptamer was prepared as a control. As shown in Figure 4-3 after incubation at 25 
o
C overnight, ligation signals were observed from reactions using 12p or 13p. In addition, 
Figure 4-3. PDGF-activated ligation activities using short oligonucleotides. 
Ligations in the presence or absence of PDGF are carried out using 12p, 13p, 14p and 
15p as splints, respectively. Also controls with only antisense strand and substrate 
oligonucleotides are used to monitor ligation ability. The predicted secondary 
structures are shown under the gel pictures. 12p serves as a splint for the ligation of 
two substrate oligonucleotides (5’SUB and 3’SUB). 13p forms half of the ligation 
junction and binds to 5’SUB. The short hairpins formed by 14p and 15p are unable to 








































stronger ligation signals were seen in the presence of PDGF than those in the absence. 
Furthermore, controls without aptamer demonstrated the ligation product of the same 
size. However, assays using splints such as 14p and 15p did not show any ligation 
activity no matter PDGF was present or not, even for the controls without aptamer. It is 
very interesting that the ligation product using 13p was bigger than that of 12p, though 
they should be of the same size. By analyzing the secondary structure of these “splint” 
oligonucleotides, we found that 12p-15p may all form stable short hairpin structures, 
which were not expected because hairpin stem as short as four basepairs was not 
considered to be so stable previously. The short hairpins formed by 14p and 15p might be 
too stable to open up (Figure 4-3), therefore it is hard for them to hybridize with the 
substrates. The same thing occured for 13p, however, the hairpin formed by 13p may 
incidentally serve as half of the ligation junction (Figure 4-3). Consequently, 13p might 
be ligated to 5’SUB, resulting in bigger size ligation product than that obtained using 
12p. On the contrary, the hairpin with three basepairs formed by 12p might be less stable, 
so 12p could serve as a template for the ligation of 3’SUB and 5’SUB.  
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To test these hypotheses, we repeated time course assays using 12p and 13p 
mediated ligations (Figure 4-4 and Figure 4-5). It took overnight incubation to detect the 
ligation signals mediated by 12p. In the presence of PDGF, the size of the ligated product 
was again about 29 mer, indicating that it was the ligation product of 3’SUB and 5’SUB.  
In addition, in the absence of PDGF, no ligation activities were observed even after 
overnight incubation (Figure 4-4). These results suggested that PDGF induced the 
separation of 12p and the aptamer and the released 12p bound to both substrate 
oligonucleotides (3’SUB and 5’SUB) for ligation.  
Figure 4-4. Time-course assay for the four-piece ligations using 12p. (A) Proposed 
ligation mechanism. (B) Ligation signals after incubation at 25 
o
C overnight. Ligated 
and unligated substrates are indicated. The ligated product (29 mer) in the presence of 
PDGF is of the same size as that of the control which does not contain aptamer and 

















































For ligations using 13p, we found that the 3’ substrate strand (3’SUB) was not 
required (Figure 4-5). In addition, the size of the ligation product was about 35 mer, 
which should be the total length of 13p and 5’SUB. Also its ligation rate was faster than 
that using 12p because PDGF-activated ligation was seen as soon as 4 hours. The faster 
ligation rate using 13p is probably due to the ease of association of two strands instead of 
three strands.  
Figure 4-5. Confirmation of the three-piece ligation system. (A) Proposed ligation 
mechanism. (B) Time course ligation assays using 13p, aptamer and substrate 
oligonucleotides. Similar ligations were carried out as those described in Figure 3-3 
except additional controls without the 3’ substrate strand (3’SUB). The ligated product 
(35 mer) in the presence of PDGF is of the same size of the control which does not 
contain aptamer and PDGF. In addition, ligation is independent on the presence of 3’ 


































































Optimization of the oligonucleotide sequences for real-time PCR  
Therefore, we obtained two ligation strategies: four-piece (12p, aptamer, 3’SUB 
and 5’SUB) and three-piece (13p, aptamer and 5’SUB). However, the ligated 
oligonucleoties were too short to generate optimal primer and probe sequences for real-
time PCR. In order to add primer and probe sequences to the ligated products, we 
extended those oligonucleotide sequences (Table 4-2). Therefore, two new substrates 
(SUB2 and N. SUB2) were created from 5’SUB and they contain either regular Taqman 
probe or MGB probe sequence. 13ntT1 and 13ntT3 are derived from 13p. SUB1 is the 
longer version of 3’SUB. Because SUB2 and N. SUB2 have identical regions, same 
reverse primers were used for all the ligations (Table 4-2). Alternative oligonucleotides
were of the same usage; therefore, we were able to test the ligation and amplification 
abilities using oligonucleotides with different but similar sequences. Because these 
redesigned oligonucleotides were longer than those initially tested, they were more likely 
to have secondary structures that might interfere with either substrate or antisense 
binding.
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The schemes of ligations using 13ntT1 (three-piece) and 12p (four-piece) with 
new substrate oligonucleotides, are shown in Figure 4-6 and Figure 4-7, respectively.  
Both 13ntT1 (13ntT3) and 12p can form duplex with the anti-PDGF aptamer in the 
absence of PDGF. In the presence of PDGF and T4 DNA ligase, 13ntT1 or 13ntT3 is 
ligated to either SUB2 or N. SUB2 and SUB1 is ligated to either SUB2 or N. SUB2 using 
12p as a splint.  
Table 4-2. Oligonucleotides used in both ligation and real-time PCR. 
TaqMan MGB probe for ligation product of SUB25’-FAM -TGATCCGATCCCTATTCA -MGB-3’BB-MGB
TaqMan probe for ligation product of N.SUB25'-FAM-CGATCCCTCTTGCTGCCTACGCA-TAMRA-3'BB probe
Forward primer for amplification of ligation of 
SUB1 and SUB2 (N.SUB2)
5’-CAAGCCTTCACAGCCTTCCTA-3’FOR12
NoteSequencesOligos
Reverse primer of all the ligations5’GGAATGAGTAGCGGACGGTAAC -3’REV
Forward primer for amplification of ligation of 
13ntT1(13ntT3) and SUB2 (N.SUB2)
5’-AGCCTTTCTCGATCGGATCA -3’FOR
5’ side ligation substrate5’-pCCGATCCCTCTTGCTGCCTACGCATGCTGTTACCGTCC-
GCTACTCATTCC-3’
N.SUB2
5’ side ligation substrate5’-pCCGATCCCTATTCATGTTACCGTCCGCTACTCATTCC-3’SUB2
3’ side ligation substrate using 12p as a splint5’-GAATCCAGTTCAAGCCTTCACAGCCTTCCTATTCATGAT-3’SUB1
Derived from 13p5’-TGGTAAGCCTTTCTCGATCGGATCATGGTGAT-3’13ntT3
Derived from 13p5’-GTGTAGCCTTTCTCGATCGGATCATGGTGAT-3’13ntT1
12nt complementary with aptamer5’-TTTGATCGGATCATGGTGA -3’12p
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Figure 4-6.  Design of 13ntT1 mediated three-piece ligation system followed by real-
time PCR. 13ntT1 (red) and N. SUB2 (blue) are derived from 13p and 5’SUB, 
respectively. 13ntT1 forms duplex with the anti-PDGF aptamer. PDGF binding to the 
aptamer displaces 13ntT1, which then forms into a small hairpin to bind to N.SUB2. 
These oligonucleotides contain forward primer (For), reverse primer (Rev) and probe 















































































Optimization of ligation time and oligonucleotide concentrations 
To couple ligation with real-time PCR assays, there are several parameters to be 
considered for gaining the highest signal-to-background ratios (deta Ct). We tested 
different oligonucleotide concentrations, ligation timeperiods, and ratios of aptamer: 
antisense in the three-piece ligation system. For the oligonucleotide concentrations, we 
tested a series of concentrations of 13ntT1. To ensure 13ntT1 totally bound to aptamer, 
more aptamers than 13ntT1 were used for ligation and three aptamer : 13ntT1 ratios 
Figure 4-7. Example of four-piece ligation followed by real-time PCR. 12p forms 
duplex with the anti-PDGF aptamer. PDGF binding to the aptamer displaces 12p, 
which then bind to both SUB1 and N.SUB2. Ligated product is subsequently 
amplified by real-time PCR. For, Rev and Probe indicate forward primer, reverse 
























































































([aptamer]: [13ntT1] = 3:1, 10:1 or 20:1) were tested. And the ratio of substrate 
(N.SUB2) : antisense (13ntT1) was always kept to be 2.5:1. For ligation timeperiods, four 
endpoints were chosen within 40 hours (Figure 4-8). A fraction of ligation reactions 
terminated at different timepoints was then used to seed a real-time PCR. As a control, a 
reaction without PDGF (but still containing BSA) was performed. Real-time PCR were 
carried out for 50 cycles and the delta Ct values were calculated by subtracting the Ct 
value for a reaction with PDGF from the Ct value for the reaction without PDGF.  
As shown in Figure 4-8, amplified ligation activities varied at different 
oligonucleotide concentrations and aptamer : antisense(13ntT1) ratios. When 13ntT1 was 
4 nM, delta Ct values obtained from the same aptamer : antisense ratios were irrespective 
of the lengths of ligation timeperiods (Figure 4-8A). However, when 13ntT1 
concentration was 0.4 nM or 0.04 nM, big deviations of ligation activities were observed 
at different ligation timepoints (Figure 4-8B and C). The greatest Ct in the regard of 
shortest ligation time and lowest oligonucleotide ratio was obtained using 4 nM 13ntT1 at 
10:1 aptamer : 13ntT1 ratio for an 8-hour ligation (Figure 4-8A). Because of this, we 
carried out both four- and three-piece ligations followed by real-time PCR using these 
above optimized conditions.  
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Figure 4-8. Optimization of detection. 4 nM (A), 0.4 nM (B) and 0.04 nM (C) 13ntT1 
were mixed with aptamers at different ratios (1:3, 1:10 and 1:20). Ligation reactions were 
carried out in the presence or absence of 40 nM PDGF-BB and then detected via real-






















































Figure 4-9. Amplified PDGF-activated ligation activities. Ligations were carried out 
using aptamer, one of the antisense oligonucleoties (13ntT1, 13ntT3 and 12p) and 
substrate oligonucleotide either N.SUB2 (A and B) or SUB2 (C and D). In the 12p 
involved four-piece ligation system, N. SUB2 or SUB2 is ligated to SUB1. Either Ct 
differences (A and C) or the amount of ligations (B and D) were analyzed for ligation 
activation.  
Real-time amplification of PDGF-activated ligations 
Using the optimized conditions, all the possible combinations of antisense and 
substrate oligonucleotides were examined in ligations followed by real-time PCR. In the 
three-piece ligations, both antisense strands (13ntT1 and 13ntT3) together with two 
substrate oligonucleotides (N.SUB2 and SUB2) were tested, respectively. In the four-
piece ligations, 12p, SUB1 and either N.SUB2 or SUB2 were assayed. A FAM-TAMRA 
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probe was designed to detect ligations by N.SUB2 and a FAM-MGB probe was used to 
detect ligations by SUB2. To find out the best combination of these oligonucleotides for 
highest signal-to-background ratio, we carried out ligations in the presence of either 40 
nM or 0 nM PDGF-BB. By comparing the obtained Ct differences shown in Figure 4-9A 
and C, ligations using N.SUB2 revealed better PDGF activation than that using SUB2 in 
both three- and four-piece assays. 
However, compared to N.SUB2, the background ligation using SUB2 was higher 
as less Ct differences were observed. Since ligation was sequence dependent, the 
secondary structure and base pairs in the splint and substrates all played important roles 
in the determination of ligation activation and efficiency. Therefore it was not surprising 
that using different ligation strategies (four- or three-piece), ligation activations and 
ligation efficiencies were varied. In comparison to the three-piece ligation, less PDGF 
PDGF (nM)


























































Figure 4-10. Dose-response for real-time PCR. Ligations were carried out using 
13ntT1, aptamer and N.SUB2 at 25 
o
C for 8 h in the presence of a series of PDGF 
concentrations. 2 µL aliquot of ligation mixture was subject to a 30-µL PCR reaction 
for 50 cycles. Amplified ligation signals were determined as a function of PDGF 
concentrations based on either (A) Ct differences or (B) the amount of ligations.  
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activation was obtained using four-piece ligations. In addition, the two antisense strands 
(13ntT1 and 13ntT3) revealed different ligation activations in the three-piece ligations. 
For instance, by ligation with N.SUB2, the Ct difference using 13ntT3 was more than 7 
while that using 13ntT1 was below 4 (Figure 4-9A). Moreover, the amount of ligated 
product was calculated and again activation folds were obtained (Figure 4-9 B and D). 
The highest activation (~150 fold) was observed with the combination of 13ntT3 and N. 
SUB2 (Figure 4-9B).  
We proposed that the sensitivities of each assay were related to the PDGF 
activation levels. In another word, the assay with the highest PDGF activation level might 
also be the most sensitive one. To determine the sensitivity of the detection, we carried 
out three-piece ligations followed by real-time PCR in the presence of a series of PDGF 
concentrations. Amplified ligation activations as a function of PDGF concentrations 
using 13ntT1 and 13ntT3 are shown in Figure 4-10 and Figure 4-11, respectively. As 
expected, ligations using 13ntT3 demonstrated sharp signal increase over all the PDGF 
concentrations tested. However, ligations using 13ntT1 revealed good response only 
when PDGF concentration was above 8 nM. These results were consistent with the 
previous phenomena observed during optimization that detection using 13ntT3 should be 
more sensitive than that using 13ntT1. Based on these, we may also conclude that the 
sensitivity using 12p mediated four-piece ligations should be even lower than that 
obtained using 13ntT1.    
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Figure 4-11. Amplified ligation activities over a series of PDGF-BB concentrations. 
Ligations using 13ntT3, SUB1 and N.SUB2 were carried out as described in Figure 4-
10. Amplified ligation signals were determined as a function of PDGF concentrations 
based on either (A) Ct differences or (B) the amount of ligation product.  
PDGF (nM)
































The specificity of the designed aptamer biosensor was also examined in the 
presence of different dimeric isoforms of PDGF: PDGF-AB, AA and BB (Figure 4-12).  













































































Figure 4-12. Specificities of response. Reactions were carried out using either 13ntT1 
(A) or 13ntT3 (B). Ligations were carried out in the presence of 40 nM PDGF-AA, -
AB or -BB. Negative controls were performed in the absence of protein or in the 
presence of BSA. 
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ligation signals given that the aptamer was originally selected to bind to the B-chain 
(Green, Jellinek et al. 1996). The signal with PDGF-BB was greater than the signal with 
PDGF-AB probably because there were more B-chains in BB than that in AB. However, 
in the presence of PDGF-AA or BSA, the amplified ligation signals were even lower than 
controls without any protein. The suppression of the background ligation by either 
PDGF-AA or BSA may caused by their competing with DNA ligases for nonspecific 
binding to the aptamer.  
Figure 4-13.  Amplification of ligation reactions performed at 25 oC within 1 hour. 
Ligations and real-time PCR were carried out using 13ntT3 as described previously 
except ligations were terminated at different timepoints within 1 hour.   










Detections in shorter ligation timeperiods 
In order to find out the feasibility of detection using shorter ligation timeperiods, 
ligations were carried out within one hour followed by real-time PCR. As shown in 
Figure 14-13, the PDGF dependent ligation activations were less than those generated by 
8 h ligations. Even ligations were carried out at elevated temperature (37 
o
C) (Figure 4-
14); the highest Ct difference was around 4, which was about half reduction of that 
obtained from 8 h ligations. In addition, these results were consistent with the PAGE 
results (Figure 4-4 and Figure 4-5) which demonstrated that there were few ligated 
products in short timeperiods. Because the highest Ct difference was about 4, like the 
13ntT1 detection, better sensitivity using shorter ligation time was not expected.  
 The advantages and problems of our design 
One advantage of our structure-switching aptamer detection strategy is that it can 
be generalized to other aptamer based detections. Like fluorescent structure-switching 
Figure 4-14. Amplification of ligation reactions performed at 37 oC within 1 hour. 
Ligations and real-time PCR were carried out using 13ntT3. In addition, different 






















aptamers, antisense strand binding to any aptamer can be designed without knowing the 
secondary or tertiary structures of the aptamers. In addition, the use of a four-basepair 
hairpin which could serve as a half of the ligation junction allow the feasibility of short 
ligation junctions, facilitating the design of more stable aptamer-antisense duplex. 
However, our design also has a couple of disadvantages. One is that ligation took 
8 hours, which is impractical for sensing. Even though a series of oligonucleotide 
concentrations and elevated temperature have been tested, ligation rates are still very low. 
And sensitive detections were hard to be accomplished in a short time period such as 1 
hour. The other disadvantage is that hybridization between aptamer and the antisense 
strands were not efficient. The 10:1 (aptamer : antisense) ratio suggested that large 
amount of aptamers were required to denature all the antisense strands. Similarly, the 
blocking oligonucleotides need to be in a 200-fold molar excess over the proximity 
probes in PLA (Schallmeiner, Oksanen et al. 2007). However higher concentration of 
aptamer would sacrifice more PDGF proteins, most of which may not be detected.   
CONCLUSIONS
Our designed structure-switching aptamers demonstrated their feasibilities for 
signal amplifications. The detection also demonstrated high specificity with PDGF-BB. 
Furthermore, this was the first example to combine structure-switching aptamers with 
real-time PCR detections. Our results suggested that the stability of the duplex formed by 
aptamer and the antisense strand, sequences and secondary structures of the designed 




In the future development, the ligation system should be improved for shorter 
ligation timeperiods and more efficient binding between aptamer and the antisense 
strands. Conditions such as hybridization time and temperature prior to ligation may be 
optimized to enhance DNA association. In addition, the lengths and sequences at the 
ligation junction may also be altered to speed up ligation rate. More importantly, 
intramolecular distance would be much closer than that of intermolecular distance. The 
shortened distance between aptamer and antisense molecules would facilitate the 
interaction among them. Therefore, combining the antisense strand and the aptamer into 
one molecule might improve detection simplicity and sensitivity.  
MATERIALS AND METHODS
Materials 
All the oligonucleotides except the TaqMan MGB probe were purchased from 
IDT (Coralville, IA). The TaqMan MGB probe was purchased from Applied Biosystems 
(Forster City, CA).  Two amplicons N. Amplicon12 (5’-
GAATCCAGTTCAAGCCTTCACAGCCTTCCTATTCATGATCCGATCCCTCTTGC
TGCCTACGCATGCTGTTACCGTCCGCTACTCATTCC) and N. Amplicon13 (5’-
GTGTAGCCTTTCTCGATCGGATCATGGTGATCCGATCCCTCTTGCTGCCTACG
CATGCTGTTACCGTCCGCTACTCATTCC) were used to generate standard curved for 
the quantitation of ligations. The sequences of oligonucleotides used in ligation and PCR 
are shown in tables 4-1 and 4-2. PDGF-BB, AB and AA were purchased from R&D 
Systems (Minneapolis, MN). PDGF proteins were reconstituted in 4 mM HCL with 0.2 
% BSA (Invitrogen, Carlsbad, CA) as suggested by the manufactures’ instruction. 
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General method for ligation using short oligonucleotides 
2 µL of 4 µM anti-PDGF aptamer and 2 µL of 2 µM antisense oligonucleotides 
were mixed in 1x ligation buffer (137 mM NaCl, 10.1 mM Na2HPO4, 1.8 mM KH2PO4,
pH 7.4, 2.7 mM KCl, 10 mM Tris-Cl, pH 7.4, and 2.5 mM MgCl2), then denatured at 70 
o
C for 3 min before cooling to room temperature. Then 4 µL of 2 µM PDGF-BB was 
added to the pre-ligation mixture. After incubation at room temperature for 60 min, 5 µL
of 2 µM substrate oligonucleotides, 1.5 µL of T4 DNA ligase (2 U/µL, Epicentre, 
Madison, WI) and 1.5 µL of 25 mM ATP were added. Ligation reactions were carried out 
at room temperature for various time periods and stopped by addition of 95 % formamide 
gel-loading buffer and heating at 95 
o
C for 10 min. Ligated and unligated species were 
separated on denaturing 8-10 % polyacrylamide gels containing 7 M urea, stained with 
SYBR Gold (Molecular probe, Eugene, OR).  
General method for ligation followed by real-time PCR  
Pre-ligation mixtures were prepared similarly as described above except that the 
final concentrations of the antisense oligonucleotide and aptamer were 4 nM and 40 nM, 
respectively. Then 2 µL of 20 nM substrates, 1.5 µL T4 DNA ligase (2 U/µL, Epicentre) 
and 1.5 µL of 25 mM ATP were added after incubation with various concentration of BB 
for 1 h. 2 µL aliquot of the terminated ligaiton reaction, 15 µL of 2x TaqMan Universal 
PCR Master Mix (Applied Biosystems ABI, Foster City, CA), 0.5 µL of 10 µM forward 
primer, 0.5 µL of 10 µM reverse primer, 0.5 µL of 10 µM MGB probe and 11.5 µL H2O
were mixed to make a total volume of 30 µL. Real-time PCR was carried out in a 96-well 
PCR plate (ABI), covered with strip caps (ABI). The thermal cycling regime was:  initial 
denaturation for 10 min at 95 
o
C, and then cycling for 15 s at 95 
o
C and 60 s at 60 
o
C, 
repeated 50 times on an ABI HT7900 real-time PCR machine. 
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Chapter 5: Real-time PCR detection of protein analytes with 
conformation-switching aptamers 
INTRODUCTION
In chapter 4, we detected PDGF-BB using structure-switching aptamers coupled 
with ligation and real-time PCR. Similar to the design of other conformation-switching 
aptamers (Nutiu and Li 2003; Bayer and Smolke 2005; Liu and Lu 2005), in our method, 
antisense oligonucleotides bind to aptamer to promote the formation of a non-binding 
conformation. In the presence of analyte, the binding conformation is more favored, and 
the displaced antisense oligonucleotide forms into a short hairpin which hybridizes to a 
substrate oligonucleotide for subsequent ligation into an amplicon. Additional sequences 
added to either end of the antisense and substrate oligonucleotides served as primer- and 
probe-binding sites for real-time PCR.   
However, the above ligation reaction required 8 hours to reach maximum analyte 
dependent activations. Such long time incubation is time-consuming for sensing in 
complex background such as serum and cellular lysate because proteases and nucleases 
may degrade oligonucleotides and analytes. In addition, the amount of aptamer needed to 
be ten times of that of the antisense oligonculeotides in order to totally occupy the 
antisense oligonucleotides. As a result, the sensitivity may be lowered by the free 
aptamers, which may take up to 90 % of the input protein analytes (Figure 5-1). When 
analyte concentration is lower than that of the aptamer low ligation rate may occur 
because either the antisense oligonucleotide is not displaced or the displaced antisense 
oligonucleotides form duplexes with other free aptamers but not the substrates for 
ligation (Figure 5-1). On the other hand, the additional primer sequence appended to the 
antisense oligonucleotide may interfere with aptamer or substrate binding, resulting in 
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difficult ligation. Therefore, we decided to increase the stability and efficiency of the 
hybridization between aptamer and the antisense by linking the antisense oligonucleotide 
to the 3’ end of the aptamer. In this way, each aptamer could be denatured by 
hybridization with an antisense sequence in cis. And by the interaction with analyte, the 
number of displaced antisense tails would reflect the exact number of analyte binding. 
Figure 5-1. Schematic diagram of the explanation of low ligation rate observed in the 
three-piece ligations. Under optimized ligation conditions, the ratio of aptamer (black) 
to antisense oligonucleotide (red) is 10:1. When analyte (PDGF) concentration is more 
than that of the aptamer, all aptamers bind to analyte and the antisense 
oligonucleotides are ligated to the substrates (green). When analyte concentration is 
below that of the aptamer, aptamers can not be totally bound. Therefore, the antisense 
oligonucleotides may not be displaced or free antisense oligonucleotides may bind to 




Moreover, primer sequences can be designed from the atpamer alone or the 
extension added on to the aptamer. Some secondary structures can be eliminated from the 
linker regions connecting aptamer and the antisense domain because the design of the 
linker region will be flexible. Therefore, the resultant two-piece ligation should be more 
suitable for real-time PCR detections.  
In this chapter, we have extended the design in Chapter 4 to a two-piece ligation 
followed by real-time PCR for PDGF detection. Following this, the method was 
generalized to another anti-thrombin aptamer. Series of optimizations of oligonucleotide 
lengths and sequences were carried out to accomplish best sensitivity. Finally, the two-
piece ligation was adapted to the design of antiswitches for the detection of PDGF and 
IgE.
RESULTS AND DISCUSSION
Two-piece ligation strategy 
In order to shorten ligation time and increase detection sensitivity, we carried out 
the design of the two-piece ligations by attaching the antisense sequence to the 3’ end of 
the aptamer. We have designed two different conformation-switching aptamers, one that 
binds PDGF and one that binds thrombin to show the generality of the method (Figures 
5-2 and 5-3, respectively). In our method, the antisense sequences (blue, in Figures 5-2 
and 5-3) were appended to 3’ end of the aptamers (red) via linker regions. The 
combination of aptamer and antisense oligonucleotide into one piece would ensure that 
each aptamer forms a non-binding conformation (Figures 5-2A, 5-3A). In the presence of 
analyte, the aptamer sequence formed the binding conformation, and its 3’ tail formed 
into a short hairpin for hybridization to an oligonucleotide substrate for subsequent 
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ligation (Figures 5-2B, 5-3B). The differences between the two designs was that the 
antisense sequence for the anti-PDGF aptamer could form a short hairpin stem itself 
while the 3’ tail of the designed anti-thrombin aptamer forms into a short hairpin by the 
assistance of additional sequence at the 3’ end of the aptamer. Additional sequences on 
either end of the aptamer served as primer- and probe-binding sites for real-time PCR. It 
should be noted that while one inhibitory conformation is indicated in Figure 5-3 two 
different, non-binding secondary structures are possible, similar to conformation-
switching aptamers previously designed by Xiao el al. (Xiao, Piorek et al. 2005). While 
both conformation-switching aptamers employ the same basic design, different 
optimization methods were explored with the two aptamers, and assay results with PDGF 
and thrombin will be described separately. In addition, we extended our design to the 
construction of antiswitches for the detection of PDGF and IgE, which will be described 
later in this chapter. 
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Figure 5-2. Sequence and secondary structure of a designed conformation-switching 
anti-PDGF aptamer. (A) Inactive conformation in the absence of PDGF. The 3’ end of 
the aptamer has been extended with an antisense sequence (blue) in order to promote 
the formation of duplex structure and denaturation of the aptamer. (B)Active 
conformation in the presence of PDGF. Formation of a three-way junction and binding 
to PDGF stabilizes a structure in which the extended 3’ end (blue) forms a short 
hairpin structure that can hybridize to a substrate oligonucleotide (green) to form a 
ligation junction. Following ligation with T4 DNA ligase, the ligated aptamer and 
substrate can be amplified by PCR using indicated forward (For) and reverse (Rev) 
primers. The position of the TaqMan probe (Probe) used during real-time PCR 








PDGF mediated ligation followed by real-time PCR 
As originally described in Figure 5-2, a conformation-switching aptamer was 
generated by appending a 13 nt antisense sequence to the 3’ end of the anti-PDGF 
aptamer via an 18 nt linker. Therefore, the aptamer should form a hairpin in the non-
binding conformation (Figure 5-2A), and assume its native binding structure in the 
presence of PDGF (Figure 5-2B). We used the same substrate oligonucleotide N.SUB2 as 







Figure 5-3. Sequence and secondary structure of a designed conformation-switching 
anti-thrombin aptamer. (A) Inactive conformation in the absence of thrombin. (B) 
Active conformation in the presence of thrombin. The active conformation of the anti-
thrombin aptamer is a quadruplex. Features of the design are as in Figure 5-2. 
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ligation junction. The same forward primer sequence (see Chapter 4) was appended to the 
5’ end of the anti-PDGF aptamer to enable real-time PCR. The probe binding site for 
real-time PCR was embedded in the substrate oligonucleotide sequence to allow real-time 
detection of amplification.  
This initial conformation-switching anti-PDGF aptamers worked well enough for 
immediate use in real-time PCR, without further sequence optimization. Optimization of 
oligonucleotide substrate (N.SUB2) concentration and ligation time prior to real-time 
PCR revealed that using 8 nM substrate at 60 minutes gave the greatest Ct with the least 
variance (Figure 5-4). Using an 8 nM substrate concentration and a ligation time of 60 
Figure 5-4. Optimization of two-piece ligation followed by real-time PCR for PDGF 
detection. Ligations were carried out for different time periods with different substrate 
(N.SUB2) concentrations. Ct differences were calculated based on the amplification of the 
sample with 40 nM PDGF and the control without PDGF. 
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min, real-time PCR was performed using a series of PDGF-BB concentrations. Delta-Ct 
represented as a function of PDGF-BB concentration is shown in Figure 5-5A. The 
lowest concentration that could be reliably detected was 0.32 nM, and the dynamic range 
of the assay extended to 40 nM.
The detections described here are consistent with the adaptation of this assay to 
clinical samples. PDGF levels in human serum have been found to be 14.4-24.8 ng/mL, 
or 0.56-1.12 nM (Singh, Chaikin, et al., 1982; Bowen-Pope, Malpass, et al., 1984). The 
sensitivities observed with our method are within these physiological levels. In addition, 
serum PDGF levels have been reported to be elevated in many diseased tissues.   
These results compare well with most other analytical methods that utilize the 
same anti-PDGF aptamer. Low nanomolar detection limits have previously been 
observed with an aptamer beacon developed by Tan’s group (Fang, Sen et al. 2003), with 
Figure 5-5. Real-time PCR amplification of PDGF-dependent ligation activities. (A) 
Signals were determined as a function of a range of PDGF concentrations. Ct 
differences were calculated relative to BSA alone (0.004 % final). (B) Specificity of 
response. Ligation reactions were carried out in the presence of 40 nM PDGF 
isoforms, respectively. Either BSA or no protein controls were also carried out.   
PDGF (nM)



























































an aptamer-based fluorescence anisotropy assay (Fang, Cao et al. 2001), with a 
colorimetric determination technique using aptamer-modified gold nanoparticles (Huang, 
Huang et al. 2005), with a luminescence detection strategy (Jiang, Fang et al. 2004), and 
with an exciton detection strategy (Yang, Jockusch et al. 2005). It should be noted, 
though, that proximity ligation coupled with real-time PCR could detect zeptomole 
amounts of PDGF (Fredriksson, Gullberg et al. 2002). However, the proximity ligation 
assay (PLA) requires two probes, rather than one, to achieve detection, and thus is not as 
generally applicable as the method we describe. 
The specificity of detection was examined by determining the Delta Ct values 
with PDGF-AA, AB, BB and no protein at all (Figure 5-5B). In the presence of PDGF-
AA, the amplified signal was much lower than the background level, while the signal in 
the presence of both PDGF-AB and -BB was significantly higher than background.  
These results accord with what is known of the anti-PDGF aptamer, as it binds to the B-
chain of the protein and has roughly equal affinity for both PDGF-AB and-BB (Green, 
Jellinek et al. 1996). As we previously observed with the conformation-switching 
aptamers (Yang, Fung et al. 2007), protein interferents (either BSA or PDGF-AA) 
appeared to actually decrease the amplified signal relative to no protein controls, perhaps 
because non-specific interactions prevented conformational changes that might normally 
have occurred in solution.  
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The sensitivity, specificity, and resilience to interferences all suggested that the 
conformation-switching anti-PDGF aptamer should also function in the presence of cell 
lysates. Figure 5-6A and 5-6B summarize the dose response and selectivity of PDGF 
detection in cell lysate. The LOD was 12.8 pM and the Ct difference with the logarithm 
of PDGF concentrations was linear within the range of 12.8 pM-8 nM. These results 
again demonstrate that our conformation-switching aptamer technology in concert with 
real-time PCR should allow the sensitive quantitation of PDGF in clinical samples. 
From the results above we can see that the two-piece ligation is faster than the 
three-piece ligation. The former takes only 1 h while the latter needs 8 h. More 
importantly, two-piece ligation can detect as low as 12.8 pM PDGF even against a 
background of cell lysate. Though similar sensitivity (64 pM) was observed for the 
Figure 5-6. PDGF detection against a background of cell lysate. (A) Ct differences as 
a function of added PDGF concentration. Signal was determined as in Figure 5-5, 
except that ligation reactions were carried out in 1 µg/mL 293T fibroblast cell lysate. 
(B) Specificity of response in a background of cellular lysate. Negative controls 
included either lysate with no additions (“lysate”) or lysate + 0.004 % BSA (“BSA”). 
















































13ntT3 mediated three-piece ligation followed by amplification, the ligation assay was 
simply done in solution. If the three-piece ligation needed to be carried out in cell lysate 
for 8 h at room temperature prior to amplification, protease, nuclease and other enzymes 
in the lysate might interfere with the ligation signals.  
Designing thrombin-sensing conformation-switching aptamers 
In order to find out the generalizability of our design, we extended the strategy 
using the anti-thrombin aptamer. In PDGF sensing, the 13 nt antisense oligonucleotide 
folded into a short hairpin, which could form the ligation junction with the substrate 
oligoncucleotide. The reason for this was because it was complementary to one of the 
hairpins of the anti-PDGF aptamer. However, unlike the anti-PDGF aptamer, the anti-
thrombin aptamer forms a free coil structure in the absence of thrombin. And it also folds 
into a quadruplex binding structure in the presence of thrombin. Therefore, no hairpin 
sequence is available from the anti-thrombin aptamer. To generate a hairpin, we first 
linked an antisense domain to the 3’ end of the anti-thrombin aptamer (Figure 5-3, blue 
sequence). Then additional sequence was added following the antisense domain. This 
sequence was designed in order to form a short stem with a portion of the antisense 
domain (Figure 5-3B).  
We also noted that in addition to adding a ligation junction and sequences for 
real-time PCR amplification to the aptamers, it was important to include spacer regions in 
order to allow both proteins (the analyte and the T4 DNA ligase) to simultaneously 
interact with the DNA. This can be seen by looking at results with a series of 
conformation-switching anti-thrombin aptamers (Figure 5-7). In initial designs, several 
different spacer lengths were used to separate the aptamer and antisense sequences. The 
spacer sequence was chosen by using the program Mfold 
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(http://www.bioinfo.rpi.edu/applications/mfold/dna/form1.cgi) to evaluate a variety of 
designs. A pyrimidine-rich spacer was found to minimize the formation of alternative 
secondary structures so that only the designed antisense sequences would pair with the 
aptamers. With the shortest spacer (21 residues; Thr9) no thrombin-dependent ligation 
was observed. When an additional T10 spacer was added (31 residues; Thr7), though, 
ligation was only observed in the presence of thrombin. When this spacer was extended 
to 20 residues (41 residues; Thr8), background ligation in the absence of thrombin 
increased. The longer spacer formed a longer loop structure that destabilized the 
interactions between the aptamer and the antisense sequence, promoting the non-binding 
conformation.    
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To further probe the relationship between sequence, conformation-switching, and 
ligation, a slightly different series of conformation-switching aptamers was synthesized 
and assayed (Figure 5-8). In this series, the T10 spacer has been repositioned within the 
Figure 5-7. Effect of spacer length on thrombin-dependent ligation. (A) Sequences of 
thrombin-sensing structure-switching aptamers that have different spacer lengths 
connecting the antisense sequence (blue) and the aptamer (red). (B) Activation of 
ligation in the presence of thrombin. Ligation reactions were carried out for 1.5 or 16 
hrs. Ligated and unligated species were visualized on 8 % PAGE gels stained with 
SYBR Gold. The percentage of ligation in the absence and presence of 500 nM 
thrombin was calculated by quantifying the amount of nucleic acid in each band using 
a QuantityOne software (BioRad Laboratories, Hercules, CA). 
Thr9   5’-TGTGGTTGGTGTGGTTGGTTCATGGTCATATTGGTTTTT CCAACCACAGTTTCTGT-3’
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aptamer, closer to the 3’ end. In addition, since it is likely that most optimizations of 
structure-switching aptamers will center on changing the number and types of basepairs 
between the aptamer and the added antisense sequences, we increased the designed 
basepairing from 9 bp (Thr7) to 10 bp (ThrX3), 11 bp (ThrX2), and 12 bp (ThrX1). 
Analyte-dependent ligation could be observed in ThrX3, but not in the two other 
constructs.  The longer stems could no longer be readily displaced by thrombin. This 
was especially interesting because the 12 bp stem in ThrX1 was identical to that found in 
other conformation-switching anti-thrombin aptamer constructs (Nutiu and Li, 2003; 
Levy, Cater, et al., 2005). However, in these previous constructs basepairing was with an 
antisense oligonucleotide in trans, not an antisense sequence in cis, and thus the number 
of designed base pairs had to be shortened to accommodate the decreased entropy of 
structural rearrangement. The fact that the position of the spacer and the number of 
designed basepairs (9 in Thr7 and 10 in ThrX3) can be changed while structure-switching 
is retained indicates the robustness of this design approach.   
These results indicated that both the Thr7 (9 bp hairpin) and ThrX3 (10 bp 
hairpin) conformation-switching aptamers were energetically poised to switch upon 
interaction with thrombin. This is important, since analyte responsivity should be highest 
when the free energy of interaction between the protein and the binding conformation of 
the aptamer is just slightly larger than the difference between the free energies of folding 
between the binding and non-binding conformations.
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Figure 5-8. Effect of antisense sequence on thrombin-dependent ligation. (A) 
Sequences of the designed constructs. (B) Ligation assays using substrates 5’P and 
t.Sub2, respectively. (+) and (-) indicate the presence and absence of 500 nM 
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Figure 5-9. Two new constructs based on the design of ThrX3 and Thr7. (A) ThrA3 
and ThrA7 were designed based on ThrX3 and Thr7, respectively. Arrows indicate the 
changes from the previous constructs. (B) Ligation assays and analyses of these two 
aptamers. (C) Amplified ligation signals using 4 sets of primers. Ligations were 
carried out in the presence or absence of thrombin using ThrA7 at room temperature 
for 20 min. Then, 2 µL aliquot of ligation reaction was used for real-time PCR. 
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ThrA3   CTCTGTGGTTGGTGTGGTTGGTTCATGGTCATATTGGTTT-T(10)-TTCCAACCACAGTCTCTGT
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The ThrX3 conformation-switching aptamer was further optimized for real-time 
PCR by changing the sequences of the probes, primers, and their complementary binding 
sites. Primer Express Software from Applied Biosystems was used for probe design, but 
initially did not identify a good probe for aptamer ThrX3. Therefore, we introduced slight 
sequence changes into ThrX3 in order to derive and utilize a better probe (and 
corresponding probe-binding site). This resulted in the production of the conformation-
switching anti-thrombin aptamer ThrA3 (Figure 5-9A) which contained a T to A change 
in the probe-binding site (underlined in Figure 5-9A) at position 63 and that could 
therefore utilize a predicted 17 nt real-time PCR probe (5’-TTCCAACCACAGTCTCT; 
this probe was obtained from ABI and was also conjugated to a minor-groove binding 
compound, as detailed in Materials and Methods). Since position 63 was also involved in 
the formation of the hairpin stem in the non-binding conformation, position 2 had to be 
correspondingly changed from A to T, in order to avoid extending the helix.  
Since the conformation-switching anti-thrombin aptamer Thr7 had also 
demonstrated excellent thrombin responsivity, we also attempted to adapt this aptamer to 
real-time PCR. The T10 spacer was again repositioned to be at the 3’ end of the aptamer 
(as with ThrX1-ThrX3) and a mutation was introduced (T61 to C61) in order to create a 
probe-binding site (underlined in Figure 5-9A) that could utilize the same 17 nt predicted 
probe sequence described above for ThrX3, ultimately creating aptamer ThrA7.   
Both new aptamers, ThrA3 and ThrA7 were assayed for their ability to ligate in 
the presence of 500 nM thrombin (Figure 5-9B; see also the following section for real-
time PCR assay development). Both aptamers retained thrombin-dependence, although 
ThrA7 gives a higher signal than ThrA3. Again, the ability to readily manipulate the 
sequences of the conformation-switching aptamers without losing thrombin-dependence 
indicates the robustness of these constructs and of the design process in general. 
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In order to facilitate real-time PCR, several different primer sequences were 
assayed (Figure 5-9C). Two different forward primers and two different reverse primers 
were designed, each of which had a predicted Tm near 60 
o
C. Real-time PCRs were 
carried out with the four possible combinations of forward and reverse primers. The best 
pair of primers proved to be t.F1 and t.R2, which generated a Ct difference in the 
presence of saturating thrombin concentrations (500 nM) of 7, which is much higher than 
is typically observed for the determination of statistically significant changes in mRNA 
expression by real-time PCR. For example, delta Ct values in the range of -0.9 to 3 were 
considered significant for quantitating diagnostically important alterations in 
hemoglobin-alpha mRNA expression levels (Nussbaumer, Gharehbaghi-Schnell et al. 
2006). Similarly, delta Ct values as low as 0.15 to 0.37 for  and  immunoglobulin light 
chain mRNA expression levels have been considered legitimate for determining B-
lymphocyte monoclonality (Stahlberg, Aman et al. 2003). Hundley et al. (2006) have 
shown that a delta Ct of less than 2 represents at least a 3.2-fold difference in the 
expression of myosin binding protein H mRNAs (Hundley, Yuan et al. 2006).  
Thrombin mediated ligation followed by real-time PCR 
The optimized conformation-switching aptamers ThrA3 and ThrA7 and the 
primer set t.F1 and t.R2 were used in real-time PCR assays for the sensitive detection of 
thrombin. In these assays, protein-dependent ligation was first carried out, followed by 
real-time amplification and detection of the ligated products. Thrombin (with BSA as a 
carrier protein) was first incubated with the aptamers for 30 minutes, and T4 DNA ligase 
and reaction components were then added. Ligation was allowed to proceed for 5-40 
minutes and stopped by heat denaturation. A fraction of the ligation reaction was then 
used to seed a real-time PCR plate. As a control, a reaction without thrombin (but still 
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containing BSA) was carried out. Delta Ct values were calculated by subtracting the Ct 
value for a reaction with thrombin (cycle threshold should be reached earlier) from the Ct 
value for the reaction without thrombin (cycle threshold should be reached later).   
As can be seen in Figure 5-10, positive delta Ct values were obtained at a variety 
of oligonucleotide (t.5’P) substrate concentrations irrespective of the length of ligation 
time, although shorter ligation times tended to provide larger signals. However, when we 
repeated the experiments, there was larger variance in Ct values at ligation times shorter 
than 20 min. Because of this, all subsequent assays incorporated a ligation time of 20 
min.  
Figure 5-10. Optimization of thrombin-dependent ligation followed by real-time PCR. 
Thrombin-dependent ligations were carried out using 0.4 nM ThrA7 and different 
concentrations of substrate (t.5’P). Ligation reactions were terminated at different 
timepoints and then amplified by real-time PCR. The Ct difference between 
amplification in the presence and absence of thrombin is indicated  
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In order to determine the sensitivity of the method, ligation and real-time PCR 
assays were performed at a series of thrombin concentrations. Delta Ct values as a 
function of thrombin concentration are shown in Figure 5-11A. The variances of the delta 
Ct values were quite low; the limit of detection (a signal three times the standard 
deviation of the background) could be detected with as little as 0.8 nM thrombin.  
Moreover, the concentration of thrombin correlated well with the real-time PCR signal 
between 0.1 and 20 nM thrombin.   
Figure 5-11. Real-time PCR amplification of thrombin-dependent ligation reactions.  
(A) Ct differences as a function of thrombin concentration. Ct differences were 
calculated relative to BSA alone (0.002 % final). (B) Specificity of response. Ligation 
reactions were carried out in the presence of either 100 nM thrombin or similar 
proteases, such as factor Xa and IXa. Either BSA or no protein controls were also 
carried out.   
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The thrombin concentration range in blood plasma is 5-500 NIH units/mL, where 
1NIH Unit=0.324+/-0.073 µg (Aronson, Stevan et al. 1977; Fenton 1986). Therefore, the 
lowest physiologically relevant thrombin concentration would be nanomolar to low 
micromolar concentrations (Lee and Walt 2000; Spiridonova and Kopylov 2002), well 
within the range of our assay.   
Our results compare quite favorably with previous aptamer-based thrombin 
assays. The observed detection limits using the anti-thrombin aptamer and optical 
biosensors varied between 1 nM (Spiridonova and Kopylov, 2002; fiber optic biosensor 
with labeled thrombin); 373±30 pM (aptamer beacon that dequenched; Li, Fang, et al., 
2002); and 429±63 pM (aptamer beacon that yielded changes in FRET; Li, Fang, et al., 
2002). For electronic biosensors the values were 2-3 nM (Radi, Acero Sanchez et al. 
Figure 5-12. Thrombin detection against a background of cell lysate. (A) Signal was 
determined as in Figure 5-11, except that ligation reactions were carried out in 1 
µg/mL 293T fibroblast cell lysate. (B) Specificity of response in a background of cell 
lysate. Negative controls included lysate with no additions (“lysate”) or lysate + 0.004 
% BSA (“BSA”). 
















































2005; Xiao, Lubin et al. 2005; Xiao, Piorek et al. 2005). Using capillary electrophoresis 
with laser-induced fluorescence detection (CE_LIF) detection limit was 40 nM and Kd
value was about 450 nM (German, Buchanan et al. 1998). When the anti-thrombin 
aptamer was adapted to the equivalent of an ELISA the limit of detection was <1 nM 
(Baldrich, Restrepo et al. 2004). The best results have been garnered by other real-time 
methods: a detection limit of 30 pM by proximity rolling circle amplification (Di Giusto, 
Wlassoff, et al., 2005), and down to several hundred of molecules by exonuclease 
protection coupled with real-time PCR (Wang, Li, et al., 2005). 
The specificity of detection was examined by substituting thrombin with other 
proteases from the clotting cascade, Factors IXa and Xa (Figure 5-11B). In the absence of 
protein or in the presence of carrier BSA, Factor IXa, Factor Xa, or in the absence of 
protein, the delta Ct signal was very small relative to the value obtained with thrombin.  
The amplified signal in the absence of any protein is again higher than that in the 
presence of BSA.  
Taken together, these results suggest that assays with physiological samples 
should also yield sensitive and specific detection, especially given that our limits of 
detection seem to be within the same range as thrombin concentrations found in 
physiological samples, as described above. In order to test this possibility, we carried out 
assays with thrombin in human 293T fibroblast cell lysates (Figures 5-12A and 5-12B).  
Despite the fact that lysate was in weight excess (for example, if thrombin concentration 
is 32 pM, lysate amount is about 845-fold of that of thrombin), the detection of thrombin 
in cell lysate was specific and sensitive as in the absence of lysate. Even though the 
signal of protein and no protein controls were somewhat higher than those in solution,  
the detection limit (a signal three times the standard deviation of the background) was 32 
pM, even lower than that in the absence of lysate (800 pM).  
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Table 5-1 summarized the sensing of PDGF and thrombin using the two-piece 
ligations followed by real-time PCR. First of all, our designed demonstrated its ability for 
protein analyte detections. The detection limits achieved by our methods are much lower 
than the Kd values of the selected anti-PDGF and anti-thrombin aptamers.  
In addition, our methods also demonstrate the generalizability to any aptamer. 
Presumably, any DNA aptamer can be designed using our strategies. We also noted that 
for each analyte detection reaction, optimizations are usually necessary for more 
sensitive, faster and simpler detections. This is because currently there is no prefect 
prediction of conformational changes available. So the sequences and the lengths of the 
designed oligoncleotides need to be fine tuned based on the feedback of the ligation data. 
In addition, ligation time, oligonucleotide concentrations and ratios are also parameters 
under concern. As shown in Table 5-1, ligation time for the detection of PDGF is 60 min, 
while that for detection of thrombin is only 20 min. Though the same aptamer 
Table 5-1. Summary of the sensing of PDGF and thrombin. 
Formed by antisense and 
additional sequences
Formed by the 
antisense sequence
3’ hairpin stem
9 nt13 ntAntisense length
0.4 nM0.4 nMAptamer 
2.68-200 nM0.1 nMKd of the selected 
aptamer
32 pM12.8 pMDetection limit 
20 min60 minLigation time
2 nM8 nMSubstrate 
ThrombinPDGF
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concentrations were used in both assays, substrate concentrations are varied (8 nM vs. 2 
nM). These differences may be caused by the different affinity of the aptamer and 
hybridization abilities of the oligonucleotides.  
Coupling antiswitches for signal amplification 
In order to find out the applicability of our method for other designs, we have 
attempted to fit our antisense-ligation strategy into the concept of antiswitch. Antiswitch 
(RNA) contains an aptamer domain and an antisense domain. The former binds to a small 
molecule analyte and the latter is a trans-acting antisense RNA which targets the 5’ end 
of mRNA in order to control gene expression at the translational level (Figure 5-13A). 
The interaction (nucleic acid hybridization) between both domains is controlled by 
analyte binding. For the “off-switch”, the antisense domain folds into a hairpin with a 
portion of the aptamer domain in the absence of analyte. Upon binding to analyte, the 
stem of the antisense domain is separated and becomes single stranded RNA, which then 
hybridizes to the target mRNA and blocks translation. For the “on-switch” the antisense 
domain is free to bind to target mRNA and suppress gene expression in the absence of 
analyte. Small molecule binding promotes to binding of the aptamer domain and the 
antisense domain, resulting in gene expression. 
One difference between antiswitch and our design is that the antisense strand in 
antiswitch is complementary to one end of the aptamer while in our design the antisense 
strand could be complementary to any portion of the aptamer. Therefore, we should be 
able to use antiswitch to carry out analyte-dependent ligations. Similar to the design of 
the thrombin-sensing structure-switching aptamer, additional sequences were added to 
the antisense strands via a linker sequence in order to generate a short hairpin to bind to 
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substrate oligonucleotide for ligation (Figure 5-13B). We have carried out the design of 
antiswitch coupled with ligation for the sensing of PDGF and IgE, respectively.  
Designing antiswitch coupled with ligation for the detection of PDGF 
Based on antiswitch (Figure 5-13A), the conformational switches are between the 
aptamer folding structure and the hairpin formed by the aptamer and the antisense. To 
create the structure switches, the aptamer’s folding conformation should be less stable 
than the aptamer-antisense duplex (inactive conformer). And in the presence of PDGF, 
the binding energy would lower the folding energy, resulting in switching to aptamer 
Figure 5-13. Coupling antiswitch with ligation. (A) The design of antiswitch for the 
control of GFP expression. In the absence of analyte, the antisense targeting the 5’ end 
UTR of GFP mRNA, forms hairpin with the aptamer. Analyte binding displaces the 
antisense strand, which then hybridizes to the mRNA and blocks GFP translation.  
(B) Design scheme of coupling antiswitch with ligation. Additional sequence is added 
to the 3’ end of the antisense domain in order to form a short hairpin in the presence of 
analyte. This hairpin structure can hybridize with a substrate oligonucleotide to form a 







binding conformation. Therefore, aptamers with truncated stem were constructed (Figure 
5-14). However, the aptamer stem should also be kept at a certain length to ensure correct 
folding. In order to find out the optimal stem lengths, we tested aptamers with stem 
lengths varying from 5 bp to 7 bp (Figure 5-14). The antisense strand in each of them 
could form 10 bp duplex with the aptamer. The difference between construct BB1 and 
BB4 was that the G in the linker of BB1 was T in that of BB4. Therefore, the secondary 
structure formed by the linker regions in BB1 and BB4 might be different due to the 
stability of a GC pair. Ligations were carried out in the either presence or absence of 
PDGF using these designed constructs and two substrate oligonucleotides, respectively. 
These two substrate oligonucleotides (PDGF.6p and PDGF.8p) could hybridize with 
either 6 bases or 8 bases in the ligation junction.  
As can be seen in Figure 5-15, no ligation signals were detected using substrate 
PDGF.6p, suggesting that the hybridization between the PDGF.6p and the displaced 
strand was so weak that there was no ligation junction formed in the presence of PDGF.  
On the contrary, the binding of PDGF.8p and the displaced strand allowed ligation to 
occur. Antiswitch BB1, BB3 and BB4 demonstrated PDGF activated ligaiton signals. In 
addition, the ligation signal generated by BB3 was stronger than that generated by BB2. 
This might indicate that the longer the aptamer stem, the easier the ligation junction is 
formed. The ligation activation using BB4 was more significant than that using BB1 
probably due to less secondary structure in the linker region of BB4. 
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Figure 5-14. Coupling PDGF-sensing antiswitch with ligation. Antisense sequence 
complementary to the anti-PDGF aptamer is appended to the 3’ end of the aptamer via 
a linker sequence so that the end sequence of the aptamer binds to the antisense 
sequence instead of the 5’ end sequence of the aptamer. Therefore the binding 
conformation of the aptamer is disrupted. Additional sequence is also added to the 3’ 
end of the antisense strand to help generate a short hairpin structure with the antisense 
in the presence of PDGF. Hybridization-switching regions are highlighted in red. A 
GC pair remained in the aptamer stem is highlighted in blue. Antiswitch constructs 
(BB1-3) have different lengths at their 5’ stems. The difference between BB1 and BB4 
is that a G in the linker of BB1 is replaced by a T in that of BB4. This G to T change is 
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Figure 5-15. Ligation assays for PDGF activation. Ligations were carried out using all 
the designed constructs (BB1-4) for 2 hours in the presence (+) or absence (-) of 40 
nM PDGF. M represents the 10-bp ladder. (A) Ligation with substrate oligonucleotide 
(PDGF.6p) which forms 6 bp stem at the ligation junction. (B) Ligation with substrate 
oligonucleotide (PDGF.8p) which forms 8 basepairs at the ligation junction. 
BB1 BB3 BB4BB2
- + - + - + - +
Aptamer
A
- + - + - + - +
Aptamer
Ligated
B BB1 BB3 BB4BB2
Substrate
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Design of antiswitch coupled with ligation for the detection of IgE 
In order to show the genralizability of the design, we have also carried out the 
adaption of the anti-IgE aptamer (Wiegand, Williams et al. 1996) to antiswitche coupled 
with ligation. To find out the length of the spacer separating IgE binding domain and the 
Figure 5-16. Optimization of the lengths of the spacers of the IgE-sensing antiswitch.
(A) Ligation scheme for the detection of IgE. The linker region is shown as a T-loop 
(blue). Complementary regions on the substrate oligonucleotides are framed in green 
boxes. The antisense and the complementary region in the aptamer are highlighted in 
red. (B) Ligation assays using aptamers with varied linker lengths. Aptamers with 
linker lengths varying from 10T to 30T were assayed with substrate IgE.7p and 
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ligation junction, a series of IgE-sensing antiswitches were designed to have different 
lengths at their linker regions. To prevent any secondary structure formed by the spacer, 
these linkers were designed containing multiple T residues. In addition, to test the 
feasibility of ligation, two substrate oligonucleotides (IgE.7p and IgE.10p) with different 
lengths in the binding regions were also constructed. Our results showed that it took 7 
days to detect ligation signals produced by substrate IgE.7p, while using the other 
substrate IgE.10p, ligation signals could be detected as soon as 4h. However, neither 
ligation assays demonstrated significant IgE-activated ligation signals. These results 
might suggest that either aptamer stem was too stable or ligation junction was too stable 
that one conformer was always dominant.  
To optimize the lengths of the substrate binding sites, we created another two 
substrate oligonucleotides (IgE.8p and IgE.9p) which can form 8 basepairs and 9 
basepairs with the IgE-sensing antiswitch, respectively. In addition, since there was no 
significant IgE-activated ligation observed previously, the binding conformation of the 
aptamer might be more stable than the antisense-aptamer duplex. Therefore, we designed 
antiswithes with truncated stems. Antiswitches IgE4-8 could form 3-7 basepairs by both 
their two termini in the active conformer. Figure 5-17 shows the ligation results using 
these antiswitches. Apparently, IgE activations using substrate IgE.8p were more 
significant than those using IgE.9p (Figure 5-17B and C). Antiswitches IgE4-7 
demonstrated significant IgE activation by ligation with IgE.8p. Furthermore, such 
activations were accomplished as soon as 1.5 h.  
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Figure 5-17. Optimization of both substrate binding sites and aptamer stem. (A) 
Conformational changes of the designed IgE-sensing antiswitches. The 5’ end 
sequences of the antiswitches IgE4-8 are indicated as well as that of the original 
sequence of the aptamer. Ligation assays using designed aptamer and either IgE.8p 
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In summary, after series of optimization, we have successfully adapted our 
method to antiswitch coupled ligation. Both PDGF and IgE antiswitches demonstrated 
significant analyte-dependent ligations. In addition, ligations could be finished within a 
couple of hours. Amrita Singh will carry out the real-time PCR assays using these 
designed antiswitches. Again, like real-time PCR detection of PDGF and thrombin 
described previously, series of optimizations of the ligation time periods, oligonucleotide 
concentrations and ratios will be performed and the detection specificity and sensitivity 
will be evaluated.  
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Figure 5-18. Summary of all the ligation strategies. In these strategies the formation 
of non-binding conformation relies on aptamer (black) hybridization with the 
antisense sequence (red). In the presence of analyte (T), the antisense sequence is 
displaced. In the four-piece ligation (A), displaced antisense strand forms ligation 
junction with a pair of substrate oligonucleotides (blue and green) for subquent 
ligation. In the three-piece ligation, antisense strand forms a short hairpin stem, which 
serves as half of the ligation junction. And only one substrate oligonucleotide (blue) is 
required for ligation. In two- and one-piece ligations the antisense sequence is attached 
to the 3’ end of the aptamer. Upon interaction with the analyte, aptamer folds into 
binding strcutre, resulting in the displaced antisense strand binding to either a 





















Taken together with the assays from Chapter 3 through Chapter 5, we have tested 
four strategies for analyte-dependent ligations (Figure 5-18). Among these four strategies, 
both the four-piece (Figure 5-18A) and three-piece (Figure 5-18B) ligations take long 
time to reach maximum activation. And the detection by the four-piece ligation is the 
least sensitive. Two-piece (Figure 5-18C) and one-piece (Figure 5-18D) ligations 
demonstrated shorter ligation time, more sensitivity and simpler operation in comparison 
to the three- and four-piece ligations. And they should be more suitable to be applied to 
sensing other analytes.  
FUTURE PLANS
The future development of such ligatable structure-switching aptamer biosensors 
can be the improvement of the sensitivities of current detections. As we described 
previously, the limitation of our method lies on the design of structure-switching aptamer. 
Because part of the analyte binding energy is used to drive the aptamer’s conformational 
change, structure-switching aptamers usually have reduced affinity with their analytes. 
Therefore, amplification techniques are necessarily to be used for magnifying the analyte-
binding. Further development of our detections might be the improvement of such 
affinity reductions. Since the short hairpin formed by the antisense domain is essential for 
the formation of a ligation junction, the sequence and the length of the hairpin stem can 
also potentially be rationally manipulated in order to further poise the aptamer between 
binding and non-binding conformations. Also base numbers and sequences at the other 
side of the ligation junction would be optimized to improve the detection. Both 
computational design and in vitro selections can be carried out to identify optimal 
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constructs for folding transitions and amplification, thus further increase the sensitivity of 
the assay. 
In addition, in principle RNA aptamers could also be adapted to our method as in 
the analyte-dependent ligation a modified RNA aptamer could be linked to either a RNA 
or a DNA substrate oligonucleotide. T4 RNA ligase 2 instead of T4 DNA ligase might be 
employed for such ligation because it catalyzes ligation of 3’ RNA strand to either DNA 
or RNA also in a template dependent manner. The ligated product could be amplified and 
analyzed by RT-PCR or transcription-mediated amplification (TMA) in real time. 
Currently, more RNA aptamers have been selected than DNA ones. The feasibility of this 




The sequences of the conformation-switching aptamers for the detection of PDGF 
were:  p.3_13 (5’-
AGCCTTTCTCGATCGGATCATTCACAGGCTACGGCACGTAGAGCATCACCAT
GATCCTGTGTTTCTTCTTCTTTTGATCGGATCATGGTGAT). The substrate for 
ligation was N.SUB2 (5'-
pCCGATCCCTCTTGCTGCCTACGCATGCTGTTACCGTCCGCTACTCATTCC), 
where p denotes a phosphate. Primers for PCR were p.F (5’-
AGCCTTTCTCGATCGGATCA) and p.R (5’-GGAATGAGTAGCGGACGGTAAC). 
The TaqMan probe used for real-time PCR was BB-PROBE-12 (5’-FAM-
CGATCCCTCTTGCTGCCTACGCA-TAMRA-3’). All oligonucleotides were purchased 
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from IDT (Coralville, IA). PDGF-BB, -AA, and -AB were purchased from R&D Systems 
(Minneapolis, MN). The PDGF proteins were reconstituted in 4 mM HCl with 0.2% BSA 
(Invitrogen, Carlsbad, CA), as suggested by the supplier. 
The sequences of the conformation-switching aptamers for the detection of 
thrombin are shown in the figures presented in this chapter. The substrates for ligation 
were t.Sub2 (5’- 
pGGTTGGCGATCCCTCTTGCTGCCTACGCATGCTGTTACCGTCCGCTACTCATT
CC) and t.5’P (5’-pGGTTGGTAGTCTCGAATTGCTCTCT). Primers for PCR were t.F1 
(5’-TGTGGTTGGTGTGGTTGGTT), t.F2 (5’-GGTTGGTTCATGGTCATATTGGT), 
t.R1 (5’-GAGAGCAATTCGAGACTACCAACC) and t.R2 (5’-
AGAGAGCAATTCGAGACTACC). All oligonucleotides except MGB probes were 
purchased from IDT (Coralville, IA).   
The MGB probe used for real-time PCR was t.MGB17 (5’-FAM-
TTCCAACCACAGTCTCT-MGB-3’) and it was obtained from Applied Biosystems ABI 
(Foster City, CA). The advantage of the MGB (minor groove binding) probe is that the 3’ 
adduct can form extremely stable duplexes with single-stranded DNA targets, leading to 
higher melting temperature and increased specificity compared with unmodified DNA 
(Afonina, Zivarts et al. 1997; Kutyavin, Afonina et al. 2000). In addition, the 3’ adduct 
acts as a quencher, leading to lower background. MGB probes can be as short as 13 
nucleotides, compared with 18-22 nt for normal TaqMan probes. MGB probes have been 
widely used for real-time PCR assays and for quantitation (Decaro, Elia et al. 2006; 
Hoehne and Schreier 2006; Lole and Arankalle 2006). 
Human -thrombin, human Factor IXa, and human Factor Xa were purchased 
form Haematologic Technologies Inc. (Essex Junction, VT). 
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Detection of PDGF by ligation and real-time PCR 
Pre-ligation mixtures contained 5 µL of 10x PDGF binding buffer (1.37 M NaCl, 
101 mM Na2HPO4, 18 mM KH2PO4 pH 7.4, 27 mM KCl, 100 mM Tris.Cl, pH 7.4, and 
25 mM MgCl2) and 1 µL of 20 nM conformation-switching aptamer p.3_13 and were 
denatured at 70 
o
C for 3min prior to cooling to room temperature. The reaction mixture 
was incubated with PDGF-BB for 30min, and then 1.5 µL of 25mM ATP (final 
concentration of 0.75 mM), and 1, 5, 10, or 20 µL of 20nM oligonucleotide substrate 
(N.Sub2, denatured prior to use) and 1 µL T4 DNA ligase (2 U/µL, Epicentre, Madison, 
WI) were added separately to make a final reaction volume of 50 µL. The final 
concentration of BSA in ligation reactions with PDGF was always 0.004 %. Ligation was 
allowed to proceed for 5 min, 30 min, or 60 min at room temperature, and was terminated 
by heating the reaction to 95 
o
C for 15 min. A 2 µL aliquot of terminated ligation reaction 
was introduced into 1x TaqMan Universal Master Mix (ABI) containing 167 nM p.F, 167 
nM p.R and 334 nM BB-PROBE-12. Real-time PCR was carried out in a 96-well PCR 
plate (ABI), covered with strip caps (ABI). The thermal cycling regime was: initial 
denaturation for 10min at 95 
o
C, and then cycling for 15 s at 95 
o
C and 60 s at 60 
o
C,
repeated 50 times on an ABI HT7900 real-time PCR machine. 
Assaying conformation-switching aptamers 
In order to test the structure-switching abilities of the designed constructs, ligation 
was assayed by gel electrophoresis. Pre-ligation mixtures (45 µL) contained 5 µL of 10x 
binding buffer (50 mM KCl, 10 mM MgCl2, and 20 mM Tris.Cl, pH 7.4), 1 µL of 10 µM
designed conformation-switching anti-thrombin aptamer and 39 µL H2O were denatured 
at 70 
o
C for 3min and cooled to room temperature. The reaction mixture was incubated 
with or without thrombin for 30 min, and then 1.5 µL of 25 mM ATP, 1.5 µL of 10 µM
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substrate (denatured prior to use) and 1 µL T4 DNA ligase (2 U/µL, Epicentre, Madison, 
WI) were added separately. The final concentration of ATP in the 50 µL ligation mixture 
was 0.75 mM, and substrate oligonucleotide was 0.3 µM. Ligation reactions were carried 
out at room temperature for various times and were terminated by heating to 95 
o
C for 
15min. Ligated and unligated species were separated on denaturing (7 M urea) 8 % 
polyacrylamide gels and stained with SYBR Gold (Molecular Probes, Eugene, OR) for 
visibility. Aptamer concentrations for ligation assays were 200 nM, higher than that used 
in real-time PCR assays (0.4 nM) in order to be visible by staining. 
Detection of thrombin by ligation and real-time PCR 
Ligaiton reactions were first carried out and then subjected to real-time PCR. The 
ligation reactions were similar to those described above except that the final 
concentration of ThrA7 was 0.4 nM and 0.002 % BSA was present. The reaction mixture 
was incubated with thrombin for 30 min, and then ATP, various amounts of substrate 
oligonucleotide (t.5’P) and 1 µL T4 DNA ligase were added separately. Ligation 
proceeded at room temperature for 20min, and was terminated by heating at 95 
o
C for 
15min. A 2 µL aliquot of the terminated ligaiton reaction, 15 µL 2xTaqMan Universal 
PCR Master Mix (Applied Biosystems ABI, Foster City, CA), 0.5 µL of 10 µM forward 
primer, 0.5 µL of 10µM reverse primer, 0.5 µL of 10 µM MGB probe and 11.5 µL H2O
were mixed to make a total volume of 30 µL. The final PCR mixture contained 167 nM 
t.F1, 167 nM t.R2, and 167nM t.MGB17 in 1x TaqMan Universal PCR Master Mix. And 
real-time PCR was carried out as detailed for thrombin detection, above. 
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Ligation in cell lysate  
To prepare lysate, approximately 1x10
7
 human 293T fibroblast cells (ATCC, 
Manassas, VA) were collected. Cells were treated with 4 mL M-PER mammalian protein 
extraction reagent (Pierce Biotechnology, Rockford, IL) and shaken at room temperature 
for 10 min. After centrifugation at 10,000 rpm at 4 
o
C for 25 min, pellets containing cell 
membranes and hydrophobic membrane proteins were removed and the supernatant 
consisting of intracellular proteins and nucleic acids was collected and frozen at -80 
o
C.  
Total protein in lysate aliquots was quantitated using a bicinchoninic acid total protein 
assay kit (Pierce Biotechnology, Rockford, IL). The final concentration of lysate proteins 
in each 50 µL ligation reaction mixture was 1 µg/mL. Protein analytes at different 
concentrations were added to the lysate and ligation and real-time PCR were carried out 
as above. PDGF samples were always in 0.004 % BSA (final concentration in 50 µL
ligation reaction) and thrombin samples were always in 0.002 % BSA (final 
concentration in 50 µL ligation reaction). 
Ligation assays using designed antiswitches 
The ligation reaction for the detection of PDGF was similar to the above 
description except the final concentrations were 0.4 µM for antiswitch constructs (BB1-
4) and 0.8 µM for the substrate oligonucleotide (BB.6p and BB.8p). 
Ligation with IgE-sensing antiswitches were carried out as following: 0.4 µM
IgE1-8 was incubated with or without 170 nM IgE in 1x PBSM buffer (137 mM NaCl, 
3 mM KCl, 8 mM Na2HPO4, 1.5 mM KH2PO4, 1 mM CaCl2, and 5.5 mM MgCl2) prior 
to ligation. After incubation at 25 
o
C for 30 min, 2 µL of 25 mM ATP, 6 µL of 10 µM
substrate (denatured prior to use) IgE.7-10p and 2 µL T4 DNA ligase (2 U/µL, Epicentre, 
Madison, WI) were added separately. The final concentration of ATP in the 50 µL ligation 
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mixture was 1 mM, and substrate oligonucleotide was 1.2 µM. Ligation reactions were 
carried out at room temperature for various times and were terminated by heating to 95 
o
C for 15min. Ligated and unligated species were separated on denaturing (7 M urea) 8 % 
polyacrylamide gels and stained with SYBR Gold (Molecular Probes, Eugene, OR).   
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